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Women fertility 
Fertility is defined as the capacity to produce offspring and it is measured with 
fertility rate, the average number of live births per women. 
In the last decades, populations of industrialized countries have experienced 
a decline in total fertility far below 2.1, which is the rate considered as 
necessary to sustain a population size at current numbers (Skakkebaek et al., 
2015) (Figure 1).  
 
Figure 1. Total Fertility Rates (TFR) measured in European Union, Japan and United States 
between 1960 and 2013. Dotted line represents a fertility rate of 2.1, below which a population cannot 
be sustained. (Skakkebaek et al., 2015) 
Fertility has become a significant political, social and economic factor.  
World Health Organization defines infertility as “a disease of the reproductive 
system defined by the failure to achieve a clinical pregnancy after 12 months 
or more of regular unprotected sexual intercourse”. This definition is based on 
the observation that 84% of women are expected to conceive within 1 year of 
regular unprotected sexual intercourse; this number rises to 92% and 93% 
respectively after 2 or 3 years (te Velde, Eijkemans, & Habbema, 2000). 
Many biological factors are known to have an impact on women fertility: some 
of them arise in the earlier stages of life, during foetal development, others 
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after birth during development. In addition, environment plays an important 
role in affecting fertility, including season and food intake (Sharpe & Franks, 
2002). 
Fertilities decline with age in both women and men but the effects of age are 
much more pronounced in women. 
Some of common medical conditions that cause female infertility are (National 
Institutes of Health): 
• Primary Ovarian Insufficiency (POI) or Polycystic Ovary Syndrome 
(PCOS) that cause failure to ovulate 
• uterine fibroid, polyps or unusually shaped uterus which can affect 
implantation and the ability to carry a pregnancy to term 
• autoimmune disorders, such as lupus, Hashimoto's and other types of 
thyroiditis, or rheumatoid arthritis 
• silent infections as untreated gonorrhea and chlamydia that can lead to 
pelvic inflammatory disease, which might cause tissue scarring that 
blocks the fallopian tubes  
• thin endometrium or endometriosis . 
Diet and lifestyle may also contribute to alter women fertility: fertility rates 
decrease in women with extreme BMI values (obesity or extreme thinness), 
whereas healthy lifestyle may help to improve fertility for women with 
ovulatory dysfunction (Clark, Thornley, Tomlinson, Galletley, & Norman, 
1998). High blood mercury concentration, due to high seafood consumption, 
is associated with infertility (Choy et al., 2002). Different studies show how 
smoking accelerates the rate of follicular depletion: on average, in smoking 
women menopause occurs on average 0.8-2 years earlier (Pawli & Szwed, 
2007) and a large meta-analysis found that smoking women are significantly 
more likely to be infertile (Augood, Duckitt, & Templeton, 1998). The effect of 
alcohol has not been clearly established on female fertility yet, but one thing 
remains certain: alcohol consumption should cease during pregnancy 
because alcohol has detrimental effects on fetal development (Bager, 
Christensen, Husby, & Bjerregaard, 2017). Additionally, high levels of caffeine 
consumption have been associated with a delayed conception (Stanton, 
1995). 
INTRODUCTION	
	 10	
Besides all these environmental causes and diseases, the ovarian reserve 
(OR) is fundamental for women fertility (see more details below). A small 
number of oocytes in initial reserve or a prematurely depletion of primordial 
follicles will result in infertility or in a shorter reproductive life span (Nelson, 
Telfer, & Anderson, 2013). 
Follicle development and ovarian reserve 
Germ cells separate from somatic cells during early stage of embryonic 
development and at this stage they are called primordial germ cells (PGCs). 
They start to multiply rapidly by mitotic division and in women they are 
transformed in oogonia. At this step, a first reserve of primordial follicles 
occurs: during fetal life, at around five months of gestational age, the ovary 
contains several million of non-growing follicles. After this initial exponential 
growth into oogonia (up to 7 million germ cell at 5 months of gestation), cells 
begin meiosis and stop in prophase-I without developing into oocytes (Fig. 2) 
(Monniaux et al., 2014). The ovarian reserve (OR) is established by a balance 
between the availability of the number of germ cells and the rate of the 
subsequent programmed cell death. Already at the time of birth the number of 
oocytes has declined to about 2 million. 
 
 
Figure 2. Numerical changes in the ovarian reserve of germ cells throughout life in humans. 
Data were obtained by histological analyses. Months p.c., months postconception (Monniaux et al., 
2014). 
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Failure in mitosis/meiosis, damage in DNA, insufficient pre-granulosa cells, 
that surround the oocyte with major functions to produce sex steroids and 
myriad growth factors, may explain why so many oocytes are produced during 
fetal development and die before birth (Kerr, Myers, & Anderson, 2013). 
Primary oocytes, surrounded by one layer of flat granulosa cells, remains in 
this shape until the beginning of puberty in the female (may remain at this 
stage for many decades). These primordial quiescent follicles support future 
ovulations throughout the reproductive life span. At puberty follicles start 
growing to full maturation and ovulation, and progressively diminish in number 
until menopause. 
During maturation follicles increase in size, they constitute the internal and 
external theca and are characterized by the presence of an antrum in the 
granulosa (Figure 3). Granulosa and theca cells continue to undergo mitotis 
concomitant with an increase in antrum volume. In women, this process is 
long, requiring almost 1 year for a primordial follicle to grow and develop to 
the ovulatory stage. 
Hormones and growth factors play a fundamental role in regulating follicles 
maturation. Gonadotropin-releasing hormone (GnRH) secreted by the 
hypothalamus stimulates the release of follicle-stimulating hormone (FSH) 
and luteinizing hormone (LH) from the anterior pituitary gland that in turn, has 
a stimulatory effect on antral follicles. When theca cells take form in the 
follicle, they show a progressive increase of LH and FSH receptors in 
granulosa cell that permit physiological maturation of follicles. Estrogen is 
fundamental in the selection of dominant follicle and a spike of LH causes 
ovulation. 
Corpus luteum, the remaining of the ovarian follicle after the release of a 
mature ovum, is involved in the production of relatively high levels of 
progesterone, moderate levels of estradiol and inhibin A. Progesterone is 
fundamental for the decidualization of the endometrium, in average every 28 
days if the egg is not fertilized, the corpus luteum stops secreting 
progesterone and degenerates in a mass of fibrous scar tissue whereas if the 
egg is fertilized and implanted, progesterone secretion continue maintaining a 
thick and bloody endometrium. 
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Figure 3. Overview of follicle development 
Age-related decline of female fertility 
Aging of females affects fertility: after the age of 30, a woman's chances of 
getting pregnant decrease rapidly every year because there is both a 
qualitative and a quantitive decline of the oocyte and follicle pool (te Velde & 
Pearson, 2002) (Figure 4). With age, also increases the probability that a 
pregnancy will terminate sooner or later after conception or implantation (e.g. 
miscarriage). 
 
Figure 4. The declining oocyte/follicle pool during woman lifetime according to Faddy et al. 1992 
 
Infertility is a global medico-socio-cultural problem especially in developing 
countries (Serour & Serour, 2017). Nowadays, reproductive behavior is 
deeply modified due to the access to high education, employment and career 
Primordial)follicle)
Primary)follicle)
oocyte)
Secondary)follicle)
Antral)follicle)
Preovulatory)follicle)
Ovula5on)
Corpus)luteum)
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opportunities, other life goals and to economic uncertainty (Mills, Rindfuss, 
McDonald, & te Velde, 2011). This has resulted in a massive delay in 
childbearing in Europe (Sobotka, 2004) (Fig.5) and also in certain highly 
educated groups in the United States (Heck, Schoendorf, Ventura, & Kiely, 
1997). 
 
 
Figure 5. Increasing average age of women at childbirth between 2001 and 2015, from an average 
of 29.0 to 30.5 years. (Source Eurostat) 
Anti Mϋllerian Hormone 
Anti Mϋllerian hormone (AMH) has become the ‘molecule of the moment’ in 
the field of reproductive endocrinology (La Marca et al., 2010). The AMH 
evaluation can essentially lead to individualization of therapeutic strategies in 
women with infertile problems (Jamil et al., 2016). 
AMH is a dimeric glycoprotein member of the transforming growth factor-beta 
(TGF-β) superfamily and its gene is located on chromosome 19p13.3 
containing 5 exons. AMH binds to its receptor (AMHR), a single 
transmembrane protein with serine-threonine kinase activity specifically 
expressed on target organs such as granulosa cells of the ovary, Sertoli and 
Leyding cell of testis. SF1, GATA1, WT1, DAX1 and SOX9 genes regulate the 
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production of AMH that has a fundamental role in sexual differentiation 
(Watanabe et al., 2000). In male fetus, AMH secreted by immature Sertoli 
cells is involved in testes development: whereas AMH leads to regression of 
Mϋllerian duct, testosterone masculinizes the fetus, stimulating the formation 
of the portions of the male anatomy, such as epididymis and seminal vesicles 
(Matuszczak et al., 2013). In female fetus the absence of AMH permits the 
rise of Mϋllerian duct and thus the development of uterus, fallopian tubes and 
the upper part of the vagina. At birth AMH is higher in males respect to 
females where it is almost undetectable; at three months of age the hormone 
dosage increases in both sexes and during childhood it is stable, but the 
onset of testosterone synthesis in males causes a rapid decline reaching the 
levels observed in healthy females (Lindhardt Johansen et al., 2013) (Fig. 6). 
The highest levels of AMH secretion in women occur between 23-25 years 
old, the most fertile period in female. 
 
 
Figure 6. Serum AMH in 1953 healthy subjects (926 females and 1027 males) according to age. 
Females: red circles, males: blue circles. Longitudinal values during infancy are connected with grey 
lines. The red and blue curves represent the female and male reference ranges, respectively (median, 
+/-2SD). The log-scale 𝑦-axes for the DSL and Gen II assays were created using the following formulas: 
AMH(IOT) pmol/L = 2.0 Å~AMH(DSL) ug/L Å~ 7.14 pmol/ug and AMH(IOT) pmol/L = 0.74 Å~AMH(Gen 
II) ug/L Å~ 7.14 pmol/ug (Lindhardt Johansen et al., 2013) 
 
In women AMH concentration essentially reflects the ovarian follicular pool 
and the reduction in the number of small growing follicles is followed by a 
reduction in circulating AMH. In fact AMH is produced by ovarian granulosa 
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cell of the preantral follicle until the stage of antral follicle when it reaches the 
differentiation state at which they are selected for dominance by the action of 
pituitary FSH (Weenen et al., 2004) (Fig. 7). 
 
 
Figure 7. AMH is secreted by pre-antral and antral follicles. 
 
AMH is secreted into the circulation and it is measurable in serum at any time 
throughout the cycle, in fact the majority of the studies underline that there is 
no fluctuation during menstrual cycle (Fig. 8) (La Marca et al., 2006; Streuli et 
al., 2008). 
 
Figure 8. Circulatory pattern of AMH during the menstrual cycle of young healthy women aged 
18–24 years. Day 0 = day of LH surge (La Marca et al., 2006). 
 
In women, AMH levels show a progressive decline during reproductive life as 
the follicular reserve decreases, becoming undetectable after the menopause. 
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The correlation between AMH and the number of growing ovarian follicles is 
also shown by the fact that high levels of AMH are present in women with 
ovarian tumors and in women with polycystic ovaries (Grynnerup et al., 2012) 
whereas it is undetectable in patients with Turner syndrome without gonadal 
tissue (Lindhardt Johansen et al., 2013). In women aged 25-40 years, a value 
of 1.0 to 3.0 ng/mL levels of AMH is considered as “normal” for fertility (Lie 
Fong et al., 2012). 
Younger women show a higher variability in concentration of AMH (Fig. 9) (La 
Marca et al., 2010), suggesting that they may underscore differences in the 
oocyte pool at young age. 
 
 
Figure 9. Serum anti-Mϋllerian hormone (AMH) concentrations throughout the reproductive 
period. Median, lower (2.5th percentile) and upper (97.5th percentile) limits and 25th and 75th 
percentiles are shown. (La Marca et al., 2010) 	
A biological role for AMH 
The slow change in AMH levels across the fertile lifespan of women (Figure 6) 
demonstrates that AMH regulates a long-term process function. 
A in vivo experiment with female mice AMH+/+ and AMH-/- prior to puberty 
(Durlinger et al., 1999) showed that the number of follicles, in both groups of 
mice, decreases with age but the decrease is faster in AMH-/- mice. This is a 
strong evidence that the pattern of AMH expression regulates primordial 
follicle activation (Pankhurst, 2017) (Figure 7, line green). These observations 
highlight that the inhibition AMH-mediated of primordial follicle activation might 
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be strongest in the early stage of reproductive life of women with a decreasing 
effect as age increases. 
A hypothesis for a potential second biological function of AMH in female takes 
into consideration the concentration of AMH in the hypothalamic-pituitary-
gonadal axis selection of follicles with a preference for high quality oocytes 
(Pankhurst, 2017). When ovarian reserve is small, there is a reduced negative 
AMH feedback, that in turn results in a more rapid depletion of follicles. This 
depletion leads to a reduced probability to have a large number of high-quality 
follicles. Whereas, when the pool of developing small antral follicles is large, 
the possibility of choosing high-quality follicles is increased (Pankhurst, 2017) 
(Fig. 10). Indeed, this model has limitations, as it has not been confirmed that 
high-quality follicles are always selected. 
 
 
Figure 10. A simplified hypothesis of quality-based follicle selection. (Pankhurst, 2017). Blu=high 
quality, red=low quality. 
Genetic variation in reproductive ageing 
Menarche and menopause are the two events that frame the reproductive life 
span in women. 
Different studies on families and twins, both monozygotic and dizygotic, 
underlined that genetic factors play a fundamental role in determining age at 
menarche with heritability h2=0.63 on average (Table 1) (Towne et al., 2005). 
Ovarian'reserve' Small'antral'follicles' Preovulatory'follicles'
High%AMH%
Low%AMH%
High%fer.lity,%%
slow%reserve%deple.on%
Moderate%fer.lity,%%
rapid%reserve%deple.on%
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Study Heritability (±se) 
Type of relative 
pairs in study No. of pairs 
Van den Ackker et al., 1987 
(London) 0.72 Unspecified twins 364 
Van den Ackker et al., 1987 
(Birmingham) 0.54 Unspecified twins 98 
Treloar and Martin, 1990 0.61–0.68 MZ and DZ twins 1,177 MZ; 711 DZ 
Meyer et al., 1991 0.71 MZ and DZ twins 1,233 MZ; 751 DZ 
Kaprio et al., 1995 0.74 MZ and DZ twins 234 MZ; 189 DZ 
Loesch et al., 1995 0.95 MZ and DZ twins 44 MZ; 42 DZ 
Snieder et al., 1998 0.45 MZ and DZ twins 275 MZ; 353 DZ 
Doughty and Rodgers, 2000 0.54±0.08 Various relative pairs 1,178 
Rowe, 2000 0.44± 0.15 Various sib pairs 505 
Kirk et al., 2001 0.5 MZ and DZ twins 1,373 MZ; 1,310 DZ 
 
Table 1. A comparison between heritability value for age of menarche estimated by various 
studies (Towne et al., 2005), (Van den Akker, Stein, Neale, & Murray, 1987), (Treloar & Martin, 1990), (Meyer, 
Eaves, Heath, & Martin, 1991), (Kaprio et al., 1995), (Loesch, Hopper, Rogucka, & Huggins, 1995), (Snieder, 
Macgregor, & Spector, 1998), (Doughty & Rodgers, 2000), (Rowe, 2000), (Kirk et al., 2001) 
The difference in each study might reflect measurement bias or the effect of 
environmental factors but all confirm that individual differences in age at 
menarche are highly heritable. 
Age of natural menopause is also largely under genetic control. The 
irreversible end of a women’s reproductive life varies widely between 50-60 
years and is modulated by both genetic and environmental factors. Only a 
small proportion of this large variation in age of menopause can be explained 
by environmental factors (van Noord, Peeters, Grobbee, Dubas, & te Velde, 
1999) with the highest effect due to smoke: smokers women have menopause 
on average 0.8-2 years earlier than non-smokers (Pawli & Szwed, 2007) 
(Figure 11).  
 
Figure 11. Age at menopause (y) grouped according to birth cohort and smoking status. 
(Rödström et al., 2003) 
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A study of twins in United Kingdom with a model specifying additive genetic 
and unique environmental variance component estimates a heritability of 63% 
[95% confidence interval (CI), 0.53-0.71] (Snieder et al., 1998). 
This high estimate of heritability was confirmed in the multi-generational 
Framingham Heart Study, a community-based epidemiological study 
(Murabito et al.  2005). Women from the original cohort collected starting in 
1948 and offspring collected later (Dawber, Meadors, & Moore, 1951) (Swan, 
2000) were analyzed: heritability was calculated using the variance-
components methods implemented in SOLAR (Almasy & Blangero, 1998) that 
takes into account the entire set of familial relationships. The separate 
estimations for (1) the original cohort, (2) the offspring and (3) for the entire 
set of women provide convincing evidence of the importance of genetic 
factors in determining both age of menarche and age of menopause (Table 
2). 
 
  n H2, mean 95% CI P value 
Original cohort 
    Crude 1500 0.65 0.42, 0.89 <0.0001 
Multivariable-adjusteda 984 0.74 0.31, 1.00 <0.002 
Offspring cohort 
    Crude 932 0.59 0.37, 0.81 <0.0002 
Multivariable-adjustedb 680 0.48 0.15, 0.81 0.003 
Pooled original and offspring cohorts 
   Crude, generation adjusted 2432 0.49 0.37, 0.61 <0.0001 
Multivariable-adjustedc 1672 0.52 0.35, 0.69 <0.0001 
 
Table 2. Estimated heritability of age at natural menopause using variance-components 
methodology in SOLAR: 1296 Framingham Heart Study families (Murabito et al., 2005) 
a. Adjusted for mean body mass index, cigarette smoking, and parity. 
b. Adjusted for mean body mass index, cigarette smoking, parity, mean alcohol intake, oral contraception use ever, 
and age at menarche. 
c Adjusted for generation (original cohort/offspring), mean body mass index, cigarette smoking, and parity. 
 
Although both menarche and menopause are under genetic control, it seems 
that there is no correlation between the onset and cessation of menstruation, 
suggesting different genetic mechanisms (Snieder et al., 1998). Many aspects 
of human women health are related to menarche and menopause 
(respectively figure 12 A and 12 B) and deep insights into the genetic basis 
may have clinical value for understanding, preventing or treating disorders of 
puberty and/or menopause.  
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Figure 12. Potential health impacts of ovarian aging. The timing of both age at menarche (a) and 
age at natural menopause (b) has a wide range of effects on human health. Shown are a range of 
conditions, in which age at menarche and age at natural menopause are known or suspected to either 
increase (↑) or reduce (↓) risks of these disorders. (Hartge, 2009) 
 
An earlier age of menarche and a later age of menopause are associated with 
an increased risk to develop breast, ovarian and endometrial cancer (Velie, 
Nechuta, & Osuch, 2005). 
Girls with earlier age at menarche tend to have higher body mass index (BMI) 
and adiposity in comparison to girls with a later age at menarche (Anderson, 
Dallal, & Must, 2003). An earlier menopause increases risk of osteoporosis 
(Khosla & Monroe, 2017). 
A set of genes involved in menopause and menarche have been found in 
recent large genetic studies when assessing the contribution of common 
variation to these physiological conditions (Stolk et al., 2012 and J. R. Perry et 
al., 2014). However, the total effect of the identified variants explains only a 
small percentage of the total hidden heritability and they are not sufficient to 
predict a potential personalized range of fertility in women. A larger 
contribution of rare variants has not been assessed yet and it might help in 
developing predictive tools and in understanding the genetic variation 
architecture that confers risk for each of the menarche/menopause-related 
disease conditions.  
The resource of isolated cohorts 
A particular resource for identifying rare variants are the genetically isolated 
populations (Varilo & Peltonen, 2004), that derive from a small number of 
founders, introducing their pool of genetic variations, and persist in a state of 
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geographical or cultural isolation for a large number of generations during 
which they do not receive any genetic contribution from the outside. They are 
also defined as “isolates”. 
Ernst Mayr (Provine, 2004) defines the 
founding effect, which intervenes at the initial 
stage of isolation, as "the formation of a new 
population from a small number of individuals 
(founders) carrying only a small fraction of the 
genetic variability from their ancestral 
populations". A population may descend from a 
small number of founders mainly for two 
reasons: either a small number of individuals colonize a previously 
uninhabited place, or a drastic reduction in population size due to sudden 
environmental changes or extreme circumstances such as famines or wars 
(bottle neck effect) (Arcos-Burgos & Muenke, 2002). The few surviving 
individuals then expand in favorable conditions. 
Isolation leads to the formation of a different genetic pool compared to the 
genome of parental or surrounding populations. A further differentiation of the 
genetic pool occurs mainly to selective adaptation and genetic drift (in the 
absence of migration). Genetic drifts act much more on small populations, 
while in large or rapidly expanding populations it is partially offset by the high 
number of progeny per generation (Cavalli-Sforza “storia e geografia dei geni 
umani” 2009). During this events some rare allele are lost due to the lack in 
founders or some may be lost in the next generation. Instead, rare alleles that 
survive during first generation could be found enriched in the isolated 
population. 
 
Characteristics of an isolated population are (1) a high degree of inbreeding 
(that might cause an increase incidence of recessive disease), (2) an increase 
in regions of homozigosity and (3) extended region of Linkage Disequilibrium 
(LD). An additional advantage of isolated populations is the environmental 
and cultural homogeneity: individuals are exposed to the same factors and in 
this way the power to identify genetic effects increased. 
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In Italy, thanks to the morphological and geographical position, there are 
several isolated populations. In 2009 it was founded the Italian Network of 
Genetic Isolates (INGI) with the aim of a large collaboration between different 
independent projects: Val Borbera, Carlantino and Friuli Venezia Giulia 
genetic park (Figure 13). 
 
 
 
Figure 13. Italian Network of Genetic Isolates:  
Val Borbera project, Friuli Venezia Giulia project and Carlantino project 
 
Val Borbera project 
The Val Borbera project started in 2005 with the aim to investigate the genetic 
factors responsible for human complex disease. Population from Val Borbera 
(VB), a large valley in Northwest Italy, isolated from the surrounding areas by 
mountains and by a deep canyon on its western side, lives in seven villages. 
According to the characteristics of the isolated population described above, 
VB population shows extended region of homozigosity (ROH) and a highest 
levels of LD compared with other populations as reported in the following 
figures (Colonna et al., 2012). 
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Figure 14. Statistics on the extension of the ROHs in the valley (a) and villages (b) with respect to 
other populations. (c) Decay of LD with increasing recombination distance measured as average 
r2 within recombination distance bins. (Colonna et al., 2012) 
An analysis of the first two principal components (PC) estimated between 
randomly selected VB samples of equal size and several populations of 
European ancestry, shows the significance of the first PC (Fig. 15). The first 
significant PC separates African from non-African populations, and the 
second PC, although not significant, distinguishes the valley from the other 
European populations, suggesting a poor recent genetic exchanges between 
the VB population and the other Italian and European populations. 
 
 
Figure 15. Population multi dimensional plot Valley: Val Borbera, VER:Veneto region, North-East 
Italy, TSI:Tuscany, Central Italy, CEU: Europe, YRI: Africa (Colonna et al., 2012). 
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Thanks to the collection of birth, marriage and death records extracted from 
church and city archives, a genealogical pedigree of about 50,000 people 
going back up to 16 generation was created. 
For this project 1,803 participants were enrolled: the sample was enriched in 
females (56%) and in older people (mean age 55 years, range 10-102 years) 
(Traglia et al., 2009) (Figure 16). 
 
 
Figure 16. Age and sex distribution of the participants to the study: 5 years periods were 
considered.In black are the males, in grey are the females (Traglia et al., 2009).	
 
Different phenotypic traits were collected including hematological parameters, 
anthropometric measures and cardiovascular values. 1785 out of 1,803 
samples were genotyped with three different Illumina chips (see materials and 
methods) and 433 out of 1,785 samples, randomly selected, were whole 
genome sequenced with a mean coverage of 6X.  
The Ethical committee of the San Raffaele Hospital in Milan and the Piemonte 
Region approved the project; all participants signed an informed consent. 
Friuli Venezia Giulia genetic park 
The Friuli Venezia Giulia (FVG) project collected 1,840 people (3-92 years of 
age) from 6 different isolated villages in the Italian FVG region (Clauzetto, 
Erto, Illegio, Resia, Sauris, San Martino del Carso). The high level of genomic 
homozygosity and the elevated linkage disequilibrium (Esko et al., 2013) 
confirmed that it is a genetic isolate. For 1,610 out of 1,840 samples genotype 
and phenotype data are available; 1,470 are adult (>=18 years). 386 samples, 
selected to better represent each of the different villages, were whole genome 
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sequenced, 200 with a mean of 4X as coverage and 186 with a mean of 10X. 
Ethical committee of the IRCCS Burlo-Garofolo approved the project and a 
written informed consensus was signed from each participant. 
Carlantino project 
Carlantino (CARL) is a small village in southern Italy in the province of Foggia. 
1,563 individuals took part to the project and for 630 individuals genotype and 
phenotype data are available. 133 samples were whole genome sequenced 
with a mean of 10X as coverage. The project was approved by the local 
administration of Carlantino, the Health Service of Foggia Province and 
ethical committee of the IRCCS Burlo-Garofolo of Trieste. Subjects gave their 
written informed consent for participating in these studies. 
 
Cohort villages participants genotyped exome chip WGS 
VBI 7 1803 1785 1803 433 
FVG 6 1840 1610 1581 380 
CARL 1 1563 630 820 133 
tot 14 5206 4025 4204 946 
 
Table 3. Data available from INGI cohort 
GWAS 
Genome-wide association studies (GWAS) are used to identify DNA variants 
and genes involved in common human diseases or with a quantitative trait or 
phenotype. The goal is to identify small variations, single nucleotide 
polymorphisms (SNPs) or small insertion or deletion (INDELs), which occur 
with different frequency in people. The study design and analysis may be 
based on case-control comparison (affected individuals versus controls) or on 
the genetic variation affecting the quantitative phenotypic variation in the 
entire population.  
The past 10 years have seen an exponential increase of associated genetic 
loci predisposing to complex diseases: thousands loci have been identified 
(Hindorff et al., 2009) and in many instances the genetic findings have been a 
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breakthrough to identify causal mechanism of disease (Voight et al., 2012) 
and biological targets for new drugs (Chatenoud, Warncke, & Ziegler, 2012). 
The GWAS catalog (source GWAS catalog), provided jointly by NHGRI and 
EMBL-EBI, is the largest collection of published GWAS including at least 
100.000 SNPs and association with p-value < 1.0 x 10-5. 
As show in figure 17 A and B great striders have been made in order to 
identify more loci associated with traits in less than 10 years. The diagram 
shows all SNP-trait associations with p-values <= 5.0 x 10-8, mapped onto the 
human genome by chromosomal locations and displayed on the human 
karyotype published by the EMBL-EBI and NHGRI GWAS catalogue. On the 
left loci identified up to June 2009, on the right loci identified up June 2017. 
 
A      B 
Figure 17. A. Loci identified up to June 2009; B. Loci identified up to June 2017. 
 
The completion of the Human Genome Project (Lander et al., 2001) and the 
improvements of technologies have allowed this spectacular result. 
Genotypes could be determined with different commercialized chip (whole 
genome or exomes) and the number of variants could be increased in 
genotyped sample using imputation, a cost-effective strategy for expanding 
the number of variants. Imputation is based on Linkeage Disequilibrium (LD) 
and permit, thanks to the availability of reference panels of sequenced 
samples of different ancestry, to infer the presence of variants and to fill 
‘holes’ in study genotypes from SNP arrays (Marchini & Howie, 2008). 
Several reference panels have been generated since 2005. The first was 
generated by the International HapMap consortium and included 269 samples 
and one million SNPs (phase I) (International, Consortium, & The International 
HapMap, 2005). Following releases were phase II with 3.1 million SNPs 
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(Frazer et al., 2007) and HapMap phase III (The International HapMap 3 
Consortium et al., 2010) with 1.6 million SNPs in 1184 individuals from 11 
populations. Finally, the last release begins to gain in imputation accuracy for 
low-frequency and rare variants. 
1000 Genome Project has permitted a further improvement in imputation 
panels. The first phase of the project combined low read depth WGS (2-4x) 
and target deep exome sequencing (50-100x) in 1092 individuals (McVean et 
al., 2012) while in phase III it was expanded to 2504 individuals from 26 
population (1000 Genomes Project Consortium et al., 2015). The advantage 
to use different populations is to obtain a profile of rare and common variants 
with considerable geographic differentiation.  
 
1000 Genomes Release Variants Individuals Populations 
Phase 3 84.4 million 2504 26 
Phase 1 37.9 million 1092 14 
Pilot 14.8 million 179 4 
 
Table 4. 1000 Genome Project data available 
 
Others panels based on WGS have been generated in different cohorts: a 
great example is the UK10K Project that collects WGS (~7x) of 3781 samples 
of British ancestry from two population-based cohorts. The UK10K reference 
panel is enriched in rare variants and increases the accuracy of imputation in 
European population (Huang et al., 2015). 
Also the Haplotype Reference consortium has combined low-read-depth WGS 
data (4-8x) from 20 studies of mainly European ancestry (McCarthy et al., 
2016) including 64.976 haplotypes. This consortium is currently continuing to 
incorporate samples from worldwide population: this effort is fundamental 
since rare variants are, on average, younger than common variants, showing 
more geographical clusters and are more difficult to impute (Bomba, Walter, & 
Soranzo, 2017). 
 
GWAS have allowed the identification of thousands of robust associations 
with complex diseases and traits but it is now required a valuable and 
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compelling annotation of the clinical and phenotypic consequences of genome 
sequence variation, through experiments for investigating the transcription, 
translation and the epigenetic regulation in order to understand the biological 
relationship between genotype and phenotype (Bomba et al., 2017). 
Statistical power limitation and the contribution of large 
consortia 
A large sample size is required to achieve an adequate statistical power. 
Since GWAS test a large number of SNP markers, this lead to a large number 
of multiple comparisons leading to an increase of false positive rates. 
Bonferroni correction (the significant threshold is set to 0.05 divided by the 
total number of SNPs analyzed) is usually applied to decrease false positives 
(Hong & Park, 2012). The genome-wide significance P-value threshold of 
5×10-8 has become a standard for common-variant GWAS (Fadista, Manning, 
Florez, & Groop, 2016). 
Genetic Power calculator developed by Purcell (Purcell, Cherny, & Sham, 
2003) under various assumption about genetic models (i.e. additive, 
dominant, recessive), allele frequencies, disease prevalence and number of 
SNPs markers permits to evaluate a correct  statistical power and sample 
size.  
For example, a smaller sample size is required with a strong effect size and 
common SNPs or under a dominant model. Nowadays with the genotype 
chips available and the possibility to infer with dense reference panel, 
enriched also in rare variants, a large sample size is required (Hong & Park, 
2012). 
The attendance of international consortia is essential to reach statistical 
power. The aim is to group different cohorts with a common interest to study 
in detail a phenotypic trait or disease. 
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Human knockout 
The study of SNPs and INDELs effects is very useful to identify human 
knockouts. The loss of function mutations (LoF) in homozygous state might 
generate a so-called ‘human gene knockout’ and which might be used as 
model to identify the function of many genes. LoF are deleterious variants in 
protein coding genes defined as frameshift, splice acceptor variant, splice 
donor variant, stop gained, stop lost, start lost, transcript ablation, transcript 
amplification.  
 
	
 
Figure 18. (A) Phenotypes associated with human knockout events can span the entire 
phenotypic spectrum and are not limited to diseases. (B) Research in human knockouts has a 
wide range of basic and translational applications. (Alkuraya, 2015) 
Phenotypes associated with human knockout events potentially span the 
entire phenotypic spectrum and are not limited to diseases. A gene with LoF 
might cause embryonic lethality or severe Mendelian diseases if the gene is 
important for life, whereas some genes might be inactivated without essential 
clinical impact, referred as LoF-tolerate genes. 
In literature, it is reported that on average every person carries ~200 variants 
predicted to cause loss of function of protein-coding gene and ~20 genes 
carrying homozygous LoF alleles and hence are likely completely inactivated 
(V. M. Narasimhan et al., 2016) (Callaway, 2014). 
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The human knockout studies represent a valuable resource in discovering not 
only genes correlated with Mendelian diseases, but also with common genetic 
diseases. This might shed light in identification of target genes for the 
development of new drug and also for studying the human phylogenetics 
(Figure 18 B).  
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During these 3 years I focused my work on genetics of fertile window in 
women life, contributing to the identification of genetic variants that regulate 
the onset of first menstruation in females, i.e “age at menarche”, and the end 
of fertile life in women, i.e. “age of menopause”. 
GWAS analyses, developed and applied in the last 10 years, provide a 
powerful approach for the discovery of variants and genes contributing to risk 
of complex diseases. In general the effect of common variants associated with 
complex traits highlighted in these previous GWAS identified only a small 
proportion of the predicted genetic variation. 
My project aimed to define the genetic architecture of age at menarche, age 
at menopause and some reproduction behaviors, testing the genetic 
contribution of low-frequency and rare variants with several approaches in 
order to improve the understanding of women infertility. 
When I started my work, different GWAS had already been performed on “age 
at menarche”. Perry et al., 2014 reported a first set of 106 loci associated 
with age at menarche: collectively these signals explained only 3% of the trait 
genetic variance. Many of these signals were already associated with other 
pubertal traits in both sexes, rare disorders of puberty and nuclear hormone 
receptors. It was also shown that some of the loci were enriched in imprinted 
regions, demonstrating parent-of-origin-specific associations. 
 
Thanks to 1000 Genome project and the possibility to impute our genotyping 
chip data to 1000G reference panel phase 3 we obtained a new resource that 
allowed to include also low frequency (1%< Minor allele frequency <5%) and 
rare variants in GWAS (Minor allele frequency <1%). In fact, from 142,722 
variants with frequency <=5% in HapMap Phase 3 Release 2 we moved to 
10,123,788 low frequency and rare variants in 1000 Genomes Project Phase 
3. In addition it was possible to increase the number of samples analyzed and 
to replicate significant results in independent group of samples (deCoDE 
study). 
In the first two chapters, I report our approaches for the GWAS analysis of 
“age at menarche” by two separate GWAS. In one we tested a dataset of 
192,974 women for low-frequency protein-coding variants genotyped by 
exome array and X-linked loci, two resources not yet investigated. A second 
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GWAS was done with a double sample size and genotype chip data imputed 
to the 1000G reference panel. 
Similar was the background of the trait “age of menopause”: 18 common 
genetic loci were already associated with this trait in two previous meta-
analysis (Stolk et al., 2012 and J. R. Perry et al., 2014) but altogether these 
variants explained less than 5% of the genetic variance in age at menopause. 
We performed a meta-analysis with a larger sample (nearly 70,000 women) 
and for the first time, low frequency coding variants were analyzed for this 
trait. 
In addition, I focused my attention on some reproduction behaviors: age at 
first birth (AFB) and number of children ever born (NEB). These could be 
best standards to measure lifetime reproductive success and to indicate 
biological fitness. In a previous published work (Tropf et al., 2015), a subset of 
6,758 samples from UK and Netherlands were analyzed and results showed 
significant additive genetic effects on both traits explaining 15% of NEB and 
10% of AFB but the underlying mechanism of AFB and NEB are poorly 
understood. We contributed to the GWAS of both traits and a meta analysis 
was performed reaching 251,151 samples for AFB and 343,072 for NEB and 
an additional a genome-wide gene-based analysis using VEGAS (Liu et al., 
2010) was performed to increase power to find statistically significant 
association. 
Thanks to the next generation technologies we whole genome sequenced 
(WGS) 947 samples from Italian Network Genetic Isolate (INGI): an extremely 
useful resource in order to build a custom reference panel to infer our 
genotypes. In comparison with 1000G reference panel, a custom panel using 
a denser scaffold of known haplotypes building with data of the same 
population, improves the imputation quality and specifically the low and rare 
frequency spectrum of variants (Cocca et al., in preparation). Very rare 
variants typical of our population could be lost with only 1000G reference 
panel due to the lack of some specific block of haplotypes. 
The analysis of these sequences also leads to the characterization of 
deleterious variants and specifically to the identification of knockout human 
genes in our population. 
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Finally, since anti mullerian hormone (AMH) is a marker of ovarian reserve, 
I have also examined in depth this trait. We have performed a GWAS on the 
quantitative trait in INGI fertile women with genotype data imputed to Italian 
Reference Panel enriched in Italian rare variants and we have conducted an 
analysis in endometriosis patients because 50% of women affected by 
endometriosis, an inflammatory disease characterized by growth of 
endometrial tissue at ectopic location, are infertile and cryopreservation could 
be considered before the accelerated follicular depletion during disease 
progression. 
 
In summary, the first 4 chapters report our GWAS results that were already 
published on menarche (Lunetta et al., 2015) (Day et al., 2017), on 
menopause (Day et al., 2015) and on human behaviors correlated to fertility, 
such as AFB and NEB (Barban et al., 2016). My contribution to all these 
papers that I coauthored has been to analyze the INGI-VB cohort and to 
participate to the global quality control for metanalyses especially in relation to 
analysis on age at menarche. 
In chapter 5, I describe how Whole Genome Sequenced INGI data was 
obtained and the analyses on human knockouts. Finally, in the last two 
chapters the results on AMH in healthy and endometriosis affected women 
are reported. 
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1. Rare coding variants and X-linked loci associated with 
age at menarche. (Lunetta et al., 2015) 
We have participated with our cohorts in GWAS organized from Reprogen 
(Lunetta et al., 2015) consortium (Reprogen) in order to study two overlooked 
sources of variants that in previous works (J. R. B. Perry et al., 2014) were not 
analyzed: low-frequency protein coding variants genotyped with exome chip 
and X-linked variants. 19 studies with a total of 76,657 European ancestry 
women were collected for the analysis with exome array data available 
(61,734 low-frequency variants – MAF <5% - passed QC). Meta-analysis for 
age at menarche (see Materials and methods - GWAS age at menarche on 
exome array), restricted to 9-17 years of age, was performed and different 
significant signals were identified. 
The most significant signal was identified in ALMS1 gene (rs45501594, MAF 
1%, P=4.6x10-10) (Fig. 18). Deleterious mutations in this gene are associated 
with Alstrom’s syndrome (OMIN 203800), a rare autosomal recessive disease 
characterized by multiorgan dysfunction and in particular sensorineural 
hearing loss, childhood obesity, diabetes mellitus, menstrual irregularities and 
hypogonadotropic hypogonadism in males (Joy et al., 2007). 
 
Our signal was confirmed in 116,317 independent women from deCODE 
(source deCODE) and 23andMe (source 23andMe) that were selected for 
follow-up. A combined meta-analysis of discovery phase and follow-up data 
permitted to identify 5 variants genome-wide significant (Fig. 19). 
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Figure 19. A ‘Manhattan plot’ of menarche association statistics for the genotyped low-frequency 
exome array variants. Test statistics are shown from the exome-chip discovery-phase samples, with 
the exception of the five labelled loci that indicate results from the combined discovery and replication 
set (Lunetta et al., 2015). 
 
Missense variant in ALMS1 remained in the combined meta-analysis the 
strongest signal with an effect size more than double (0.23 years later age in 
puberty) than any genetic variant previously reported for this trait. 
 
A rare stop-gain (rs144292455, MAF=0.08%) in TACR3 (tachykinin receptors 
3) is associated with 1.25 years-later age at menarche with combined p-value 
= 2.8 x 10-11. This premature stop codon in TACR3 (p.W275X) is associated 
with hypogonadropic hygonadism (IHH), a rare reproductive disorder 
(Phenotype MIM number: 614840). This variant both in homozygous and 
heterozygous state have been already reported in male with ‘early androgen 
deficiency’; however heterozygous cases in IHH showed evidence of 
spontaneous neuroendocrine recovery. 
 
rs35713889 (MAF = 4%; P=1.1 x 10-11) is associated with 0.08 years-later age 
at menarche and it is a missense variant in LAMB2 gene that encodes a 
subunit of Laminin, a glycoprotein in extracellular matrix fundamental for 
organization of the cell, for migration and attachment. Mutations in LAMB2 
cause Pierson’s syndrome (OMIM 609049) characterized by congenital 
nephrotic syndrome and ocular anomalies. Common variants in or near other 
Laminin genes have already been reported as associated with different 
complex traits including colorectal cancer, coffee consumption, type 2 
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diabetes. 
TNRC6A is a member of the trinucleotide repeat containing 6 protein family 
with a role in post-transcriptional gene silencing through the RNA interference 
(RNAi) and microRNA pathways. rs113388806 in this gene is associated with 
later age at menarche (p=1.1 x 10-11, MAF= 4.7%) and this finding increases 
the number of epigenetic mechanisms implicated in the regulation of puberty 
(Lomniczi, Wright, & Ojeda, 2015). 
 
The last significant signal in combined meta-analysis is a low frequency 
missense variant (rs1126930, p=9.6x10-11, MAF=3.4%) in PRKAG1 gene 
which encodes a regulatory subunit of the AMP-activated protein kinase 
(AMPK). AMPK is an important energy-sensing enzyme that monitors cellular 
energy status and it is activated in response to cellular metabolic stresses. 
PRKAG1 is overexpressed in ovarian carcinomas (Li, Liu, Chiu, Chan, & 
Ngan, 2012). 
GWAS on X-chromosome 
A second GWAS was performed with data on X-chromosome imputed with 
1000 Genome reference panel in up to 76,831 women available thanks to 
23andMe database (see Materials and methods - GWAS age at menarche on 
X chromosome). Our results identified two significant signals in/near IGSF1 
and FAAH2, both association were confirmed in 39,486 women from deCODE 
project. 
 
IGSF1 encodes the immunoglobulin superfamily member 1 high expressed in 
the pituitary gland and testis and common variants (lead SNP: rs762080, 
MAF=24%, p=9.4x10-13) in this gene are robustly associated with age at 
menarche in our analysis. In literature rare mutations in IGSF1 are associated 
with hypotiroidism, delayed puberty and macro-orchidism in males (OMIM 
300888). 
 
The second significant signal on X-chromosome is in the intronic region of 
FAAH2 (rs5914101, MAF=24%, p=1.9x10-10): this is a critical region for 
Turner’s syndrome, a genetic condition that affects development in females 
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and cause primary ovarian insufficiency. 
Gene expression data 
In order to further characterize the function of significant signals, an additional 
analysis was performed on the 7 significant genes using expression data on 
53 tissue types from Genotype-Tissue Expression consortium. Genes, as 
showed in the following figures, have a high relative tissue expression in ovary 
and hypothalamus (Figure 20) but any significant associations were found 
with mRNA transcript abundance. 
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Figure 20. Relative gene expression profiles of highlighted genes using GTeX  
(Lunetta et al., 2015) 
 
Based on this evidence, we might conclude that genetic architecture of 
puberty timing is a complex set of hundred or even thousands of variants, 
similar to other complex traits. In fact several low-frequency exonic variants 
and two common signals on X chromosome that reach the significance 
threshold explained only 0.5% of the variance of age at menarche in the 
deCODE study. This suggests that also these genetic sources are not enough 
to find the missing heritability of menarche. 
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2. Genomic analyses identify hundreds of variants 
associated with age at menarche and support a role for 
puberty timing in cancer risk. (Day et al., 2017) 
Thanks to the coordination of ReproGen consortium a second meta-analysis 
on age at menarche (AAM) was performed. 
In comparison to previous study (Lunetta et al., 2015) in this analysis the 
sample size doubled and genotype chip data was imputed to the 1000G 
reference panel, a more dense panel (see Materials and methods - GWAS 
age at menarche imputed to 1000G). 329,345 women of European ancestry 
participant were included in the analysis, 179,117 from ReproGen consortium 
(40 studies), 76,831 from 23andMe (source 23andMe) and 73,397 from UK 
Biobank study (Collins, 2012). In total 389 indipendent signals (37,925 
variants) were associated with AAM with P < 5 x 10-8 across all 23 
chromosome (Fig. 21). 
 
 
Figure 21. Manhattan plot displaying the genomic locations of the 389 genome-wide significant 
loci. Previously identified genome-wide significant loci are shown in gold, and new loci are shown in 
purple. SNPs within 300 kb of the lead SNP at each locus are highlighted (Day et al., 2017). 
 
A subset of 42 index variants were selected because they have a per-allele 
effect range from ~1 week to 5 month. Among these, 16 variants have low 
frequency (MAF <5%) and 26 are INDELs. 
A replication in deCODE study showed concordant direction of the effect for 
367 signals (94.3%) and a combined meta-analysis revealed 368 significant 
signals. The 389 index SNP in aggregate explained 7.4% of the variance in 
deCODE and 7.2% in UK Biobank, corresponding to ~25% of the estimated 
heritability of trait. An analysis on age at voice braking in 55,871 men in 
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23andMe shows a strong sharing with genetic architectures of AAM in 
women. 327 of 389 AAM signal have directionally consistent trends. 
Implicated genes and tissue 
Different analyses were performed to study the implicated genes in AAM: 
mapping of non-synonymous SNPs, expression quantitative trait locus 
analysis (eQTL) and integration of Hi-C chromatin-interaction data. 
In total 32 gene have non-synonymous variants (8 lead SNP and 24 high 
correlated – r2>0.8) (Tab. 5) and are located in genes disrupted in rare 
disorders of puberty: GNRH1, FUT2, KISS1 and CYP19A1. 
Chr.	 Position	 r2	 rsID	 Ref.	Seq.Name	
dbSNP	functional	
annotation	
1	 204190659	 0.96	 rs4889	 KISS1	 NSM	
3	 88140191	 0.98	 rs7653652	 ZNF654	 NSM;INT	
3	 184321878	 0.88	 rs2178403	 EIF4G1	 NSM	
4	 94249688	 0.93	 rs11722476	 SMARCAD1	 NSM	
5	 64724489	 1	 rs80170948	 SREK1IP1	 NSM	
5	 168506153	 1	 rs2305734	 RARS	 NSM	
6	 29792252	 0.95	 rs45479291	 HCG4	 NSM	
6	 41936044	 0.82	 rs1051130	 CCND3	 NSM	
6	 75634715	 0.99	 rs17414086	 SENP6	 NSM	
6	 75715572	 0.92	 rs9250	 SENP6	 NSM	
7	 130023656	 1	 rs11556924	 ZC3HC1	 NSM	
8	 25423284	 1	 rs6185	 GNRH1	 NSM	
8	 52940311	 0.94	 rs33977775	 NPBWR1	 NSM	
9	 7174673	 1	 rs913588	 KDM4C	 NSM	
9	 108965390	 0.81	 rs7021366	 CTNNAL1	 NSM	
9	 109119576	 0.86	 rs1051474	 TMEM245	 NSM	
11	 237087	 0.87	 rs1045288	 PSMD13	 NSM	
11	 244106	 0.91	 rs10902112	 PSMD13	 NSM;INT	
11	 244108	 0.91	 rs7107362	 PSMD13	 NSM;INT	
11	 244115	 0.91	 rs7128044	 PSMD13	 NSM;INT	
11	 244129	 0.88	 rs7116130	 PSMD13	 NSM;INT	
11	 244141	 0.88	 rs7128029	 PSMD13	 NSM;INT	
11	 27658369	 0.86	 rs6265	 BDNF	 NSM	
11	 119172947	 0.81	 rs643423	 NLRX1	 NSM	
11	 119182117	 0.83	 rs4245191	 NLRX1	 NSM	
11	 119188695	 1	 rs1815811	 PDZD3	 NSM	
12	 108224853	 1	 rs3764002	 WSCD2	 NSM	
14	 60437039	 0.9	 rs1254319	 C14orf39	 NSM	
15	 51222375	 1	 rs28757184	 CYP19A1	 NSM	
15	 74044292	 1	 rs5742915	 PML	 NSM	
16	 19872042	 0.88	 rs61742688	 GPRC5B	 NSM;SYN	
16	 20359488	 0.9	 rs9652588	 PDILT	 NSM	
16	 20359494	 0.9	 rs9652589	 PDILT	 NSM	
16	 24793633	 1	 rs113388806	 TNRC6A	 NSM	
17	 81246424	 0.93	 rs2725405	 SLC38A10	 NSM	
19	 1819126	 0.91	 rs2396359	 REXO1	 NSM	
19	 35733804	 0.88	 rs231591	 KMT2B	 NSM	
19	 48703417	 0.85	 rs601338	 FUT2	 NSN	
19	 48703728	 0.96	 rs602662	 FUT2	 NSM	
19	 58478128	 0.94	 rs893185	 ZNF446	 NSM	
20	 56248973	 0.98	 rs3827103	 MC3R	 NSM	
 
Table 5. Non-synonymous variants (Day et al., 2017)  
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In order to understand if significant variants influence gene expression, public 
gene expression dataset were examined (see Materials and methods – Gene 
expression data integration). First, a comparison was done with available 
whole-blood eQTL data set published by Westra (Westra et al., 2013): 
Summary Mendelian Randomization approach (Zhu et al., 2016) prioritized 
113 transcripts, 60 of which had evidence for causal or pleiotropic effects (see 
Materials and methods - Mendelian Randomization analyses). Secondly, an 
analysis on 46 GTEx tissues have shown that 5 tissues, involved in central 
nervous system, are positively enriched for AAM (Figure 22). Later AAM was 
associated with higher transcript levels of LIN28B in the pituitary, NCOA6 in 
the cerebellum and HSD17B12 in various tissues. 
 
 
Figure 22. GTEx tissue enrichment using LD score regression. Numbers on the x axis correspond 
to sample number for each tissue. The dashed line represents significance at FDR < 5%, and the solid 
horizontal line represents Bonferroni-corrected significance for the number of tissues tested (Day et al., 
2017). 
 
335 of the 389 loci were located in regions of chromatin looping containing 
chromatin contact points (TADs): data of significant Hi-C interactions and 
contact domains were obtained from Rao at al (Rao et al., 2014) in order to 
identify possible distal causal genes. 66 signals have a direct physical 
connection; in fact they are located in a specific contact point. 22 meta-
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analysis significant signal, that were in gene desert regions, were in TADs 
contained notable distal candidate genes as INHBA, BDNF, JARID2 and 
several other AAM signals resided within one TAD containing the same single 
gene for example TACR3 with a signal in 5’UTR, 2 signal upstream and 1 
signal downstream. 
Transcription factor binding enrichment 
2382 transcription factors were tested, in order to identify network involved in 
regulation of AAM, combining DNase-1 hypersensitive sites and chromatin 
sites in 111 cell types and tissue. 
16 transcription factor binding motifs were enriched for co-occurrence with 
AAM-associated variants (Table 6). 
 
Transcription	
factor	 Genes	 Start	 Stop	 FDR	
ELF1_1	 13	 41506055	 41556418	 0.000685671	
SPIC_1	 12	 101871335	 101880775	 0.000840042	
SPIB_2	 19	 50922195	 50934309	 0.003093769	
TEAD1_4	 11	 12695969	 12966284	 0.00600102	
MYF6_2	 12	 81101408	 81103256	 0.007099359	
GATA_3	 -	 	 	 0.008257109	
CTCF_1	 16	 67596310	 67673088	 0.010031085	
FOXC2_1	 16	 86600857	 86602537	 0.015555478	
HESX1_1	 3	 57231944	 57234280	 0.015559573	
RXRB_1	 6	 33161362	 33168630	 0.017855659	
NR2F1_2	 5	 92919043	 92930315	 0.018061308	
TAL1_5	 1	 47681962	 47698007	 0.0190937	
NR2C2_1	 3	 14989091	 15090786	 0.019105021	
SMAD3_3	 15	 67358195	 67487533	 0.027643611	
PITX1_1	 5	 134363424	 134369964	 0.036859677	
MSX1_5	 4	 4861392	 4865660	 0.039625118	
 
Table 6. transcription factor enriched for co-occurrence with AAM-associated variants. 
False Discovery Rate < 0.05 (Day et al., 2017). 
Pathway analyses 
Software MAGENTA (Ayellet et al., 2010) was used to identify pathway 
associated with AAM: ten pathways reached the significance (see Materials 
and methods – Pathway analyses). Five out of 10 pathways were related to 
transcription factor binding and the other five pathways were related 
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respectively to peptide hormone binding, PI3-kinase binding, angiotensin-
stimulated signaling, neuron development and γ-aminobutyric acid (GABA)-
type B receptor signaling. 
The strongest AAM signal is in LIN28B gene, which is linked to the repression 
of let-7 family of microRNAs. From literature we know that let-7 miRNA targets 
are enriched for variants associated with type 2 diabetes and transgenic 
Lin28a/b mice demonstrate that both alter pubertal grown and glycaemic 
control. This suggest that there could be a link between puberty timing and 
type 2 diabetes in humans. 
Imprinted genes and parent-of-origin effects. 
This findings confirmed enrichment in imprinted genes associated with age at 
menarche (Table 7), in particular we identified a rare 5’ UTR variant 
rs530324840 in MKRN3 and a rare intergenic variant at the DLK1 locus both 
associated with AAM under the paternal model but not under the maternal 
one (see Materials and methods – Parent-of-origin-specific associations and 
variance). 
 
Table 7. Parent-of-origin-specific associations between sequence variants at MKRN3, DLK1 and 
MEG9 and AAM in Iceland (N = 39,543) (Day et al., 2017) 
aThe effect of allele A1 in years per allele. bP value for heterogeneity between paternal and maternal 
allele associations. crs530324840 is a new variant identified by the parent-of-origin-specific analysis. 
rs184950120 is the rare variant identified by the meta-analysis. rs12148769 is the previously reported 
intergenic common signal (ref. 3). drs138827001 is a new variant identified by the parent-of-origin-
specific analysis. rs10144321 and rs7141210 are previously reported common variants (ref. 3). 
ers61992671 is a suggestive new parent-of-origin-specific association signal.		
 
Disproportionate genetic effects on early or late puberty timing. 
The impacts of genetic and environmental factors show age-related 
difference: heritability and effect are higher for early AAM than for late AAM 
(h2snp= 28.8% for early and h2snp= 21.5% for late AAM). 57.7% of autosomal 
index SNPs had larger effect estimates on early than on late AAM. 
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Effects of puberty timing on cancer risk 
Increasing AAM, using a model adjusted for BMI, was associated with lower 
risk for breast and ovarian cancer in women; this could be mediated by a 
shorter duration of exposure to sex steroids. 
 
All this findings suggest the genetic complexity of the puberty regulation and 
the large set of new associated genes discovered.  
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3. Large-scale genomic analyses link reproductive aging to 
hypothalamic signaling, breast cancer susceptibility and 
BRCA1-mediated DNA repair. (Day et al., 2015) 
Natural age of menopause (ANM), as already reported, has a substantial 
impact on infertility: it is estimated that fertility ceases 10 years before 
menopause and this could be relevant for women that decide to delay 
childbearing. Early menopause is associated with many aspect of human 
health: a lower risk of breast cancer but higher risks of type II diabetes, 
cardiovascular disease and osteoporosis. 
The aim of this study is to analyze both common and low-frequency coding 
variants that influenced natural age of menopause (ANM): a meta-analysis of 
up to 69,360 women of European ancestry with genotype date imputed to 
HapMap2 and a meta-analysis of up to 39,026 women genotyped on exome 
arrays were performed with ANM as trait (see Materials and methods - GWAS 
age at menopause on all genome and GWAS age at menopause on exome 
chip data). 
54 independent signals across the genome were significant associated (1,208 
SNPs with P< 5X10-8) and their minor allele frequency ranged from 7 to 49% 
and effect size from 0.07 to 0.88 years for allele with no significant 
heterogeneity between studies. The top 54 SNPs explain 6% of the variance 
in ANM, if we consider the top 29,958 independent variants with P< 0.05 the 
variance explained increase to 21% (Table 8) (see Materials and methods - 
Estimating variance). 
Cut	Off	for	SNP	set	 Number	of	SNPs	
Variance	
Estimate	 SE	 p	
All	QD'd	(unclumped)	 2797986	 0.3407	 0.1789	 0.02676	
0.05	 29958	 0.2099	 0.0974	 0.01261	
0.005	 5602	 0.1717	 0.0466	 6.47E-05	
5.00E-04	 1070	 0.0848	 0.0242	 4.16E-05	
5.00E-05	 378	 0.0825	 0.0186	 1.33E-09	
5.00E-06	 208	 0.0785	 0.0177	 2.50E-12	
5.00E-07	 128	 0.0604	 0.0161	 2.06E-11	
GWAS	sigificant		 54	 0.0567	 0.0161	 6.26E-12	
 
Table 8. Estimation of variance (Day et al., 2015) 
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Using variants from exome array, we identified only one significant signal: two 
low-frequency highly correlated (r2=0.73, D’=1) missense variants in HELB 
gene, a DNA helicase that unwinds DNA during replication, transcription, 
repair. A combined analysis with our women and other 10,157 sample from 
deCODE study confirmed the signal on HELB and found a new one on 
SLCO4A1 gene, a solute carrier that transport organic anions such as thyroid 
hormones and estrone-3-sulfate. Both this signals, in HELB and in SLCO4A1, 
were identified also by our HapMap 2-based GWAS meta done in parallel (in 
purple in figure 23). 
 
Figure 23. Miami plot of HapMap and exome SNP associations. Log-transformed P values are 
shown for association with ANM for SNPs from HapMap 2 (top; pink) and SNPs from the meta-analysis 
of exome chip data (bottom; blue). Previously known signals are shown in gray, and newly discovered 
signals are shown in red (HapMap 2) or purple (exome chip and HapMap 2). The yellow lines 
correspond to genome-wide significant levels in each direction; the gray lines indicate where the y axis 
has been truncated (Day et al., 2015). 
The common rs12371165 in HELB is fully explained by the two rare exome 
chip SNPs which are in high LD each other (Figure 24). The substitution of 
aspartate by a non polar residue at amino acid 506 of DNA helicase B affect 
the binding of the helicase to replication protein A as demonstrated with 
functional studies (Guler et al., 2012). The three significant variants on 
SLCO4A1 are non-redundant signals, the association with each of these 
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variants are unaffected by the presence of the others two. 
 
	
Figure 24. Multiple signals at HELB and relationship to DNA helicase B protein sequence. 
Positions are given in Build 37 coordinates of the reference genome. The top signal from the exome 
chip analysis maps to an acidic motif of DNA helicase B and results in the replacement of an acidic 
aspartate residue by a nonpolar glycine residue (Day et al., 2015). 
ANM SNPs strongly enriched in DNA damage response pathways 
Enrichment in pathway involved in DNA damage response (DDR) among the 
significant signal resulted from an analysis using MAGENTA (Ayellet et al., 
2010): 29 regions GWAS-significant contain one or more DDR genes within 
500kb (see Materials and methods – Pathway identification) (Figure 25). 
rs1799949 on chr7 with p-value 8.4x10-11 is highly correlated with 4 common 
non-synonymous variants in BRCA1; this signal is an eQTL for BRCA1 in 
multiple tissues, including blood, skin, brain and adipose. The data show that 
ANM-lowering allele reduce BRCA1 expression in blood; BRCA1 directly 
inhibits the transcriptional activation function of ERα and the altered estrogen 
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signaling could in turn affect ANM. A STRING (Szklarczyk et al., 2015) 
analysis identified 15 ANM signal direct linked to BRCA1 and in particular 7 
genes encoded binding partner of BRCA1 (BRE, MSH6, POLR2H, FAM175A, 
UIMC1, RAD51 and CHEK2).  
In addition to genes involved in homologous recombination for the repair of 
double-strand breaks as BRCA1, other DDR mechanism are presented from 
ANM signals: MSH5 e MSH6 genes as an example of mismatch repair, 
APEX1 and PARP2 involved in base-excision repair, CHEK2 and BRSK1 as 
damage checkpoint. This show how DNA damage during fetal development 
could results in apoptosis and thus in a reduction of oocytes pool both during 
mitosis and meiosis phases of oocyte development. 
 
Figure 25. Classification of the genes identified as being involved in DDR pathways at genetic 
loci associated with ANM (Day et al., 2015). 
ANM SNPs enriched in known POI genes and correlation with other 
traits and disease 
Four GWAS significant regions are in or near genes already reported 
associated with POI: MCM8 (Desai et al., 2017), EIF2B4 (Fogli et al., 2003), 
POLG (Trifunovic et al., 2004) and MSH5 (Mandon-Pépin et al., 2008). In 
particular recessive mutations in MCM8 identified in a recent study (AlAsiri et 
al., 2015) show as deficiency in double-strand break repair cause DNA 
instability with a great effect on the oocyte pool causing depletion of oocytes 
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and thus ANM. 
We identified an overlap between the significant signals and GWAS catalog 
for other traits as liver enzymes, lipids, urate, height and fasting glucose but 
no one overlap with any autoimmune traits. 
Significant signals for GWAS ANM were found in or near 5 genes reportedly 
causal for hypogonadotropic hypogonadism: CHD7, FGFR1 and SOX10 
already involved in Kallmann syndrome (anosmic hypogonadotropic 
hypogonadism due to failure of embryonic migration of gonadotropin-releasing 
hormone (GnRH)-secreting neurons from the olfactory bulb to the 
hypothalamus (Silveira & Latronico, 2013)), KISS1R encoded the receptor for 
kisspeptin (a key hypothalamic activator of the reproductive hormone axis) 
and TAC3 encoded a member of the tachykinin family of secreted 
neuropeptides. Recent studies have identified expression of TAC3, KISS1R 
and kisspeptin in ovarian granulosa cells: these neuropeptides and their 
receptors could have a peripheral action (Garcìa-Ortega et al., 2014). 
A Mendelian randomization approach was used to test the causal relationship 
between breast cancer and ANM: a positive correlation between the risk of 
breast cancer and increasing in ANM was identified due to the probability of 
prolonged estrogen and progesterone exposure. 
 
In conclusion, we underlined the importance of repair DNA mechanisms: in 
fact during fetal development 7 million of oogonia are produced by mitosis and 
DNA damage in this phase and during recombination at meiosis could cause 
apoptosis and a reduction of the initial oocyte pool. Aberrant repair throughout 
life could affect the rate of atresia and thus ANM. Also this work underlines the 
usefulness of genetics in identifying biological pathways in the studied traits. 
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4. Genome-wide analysis identifies 12 loci influencing 
human reproductive behavior. (Barban et al., 2016) 
We examined in depth two traits strictly connected to fertility: age at first birth 
(AFB) and number of children ever born (NEB), in collaboration with Nicola 
Barban from University of Oxford. Human reproductive behavior may 
influence the fitness, infertility and also risk of neuropsychiatric disorders. In 
industrialized societies prenatal, infant and child mortality is reduced thanks to 
improvement in care and hygiene and so NEB could be an optimal standard to 
measure lifetime reproductive success indicating biological fitness. 
A large meta-analysis of 62 cohorts of European ancestry (251,151 and 
343,072 individuals respectively for AFB and NEB) was performed separately 
for men, women and both sex combined for the two traits. For AFB analysis 
only people with offspring were considered, while for NEB trait only men with 
age >= 55 years and women >=45 years (end reproductive period) were 
included in the analysis. AFB and NEB analysis showed respectively 10 loci 
significantly associated (9 in both sex combined and one in women only) and 
3 loci (2 in both sex combined and 1 only in men) (Fig. 26, Tab. 9).  
Figure 26 (a,b). SNPs are 
plotted on the x axis 
according to their position on 
each chromosome against 
association with AFB (a) and 
NEB (b). The solid blue line 
indicates the threshold for 
genome-wide significance (P < 
5 × 10−8), and the red line 
represents the threshold for 
suggestive hits (P < 5 × 10−6). 
Blue points represent SNPs in a 
100- kb region centered on 
genome-wide significant hits. 
Loci are annotated with the 
names of the genes closest to 
the significant SNPs. (Barban et 
al., 2016) 
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Table 9. The rows in bold correspond to the 
independent signals reaching P < 5 × 10−8 in the 
meta-analysis. Annotation shows for each of the 12 
independent lead SNPs (excluding rs10908474 on 
chromosome 1) whether it is (i) in strong LD (r2 > 0.8) 
with a nonsynonymous variant (N) or one or more 
variants prioritized by RegulomeDB (R) with evidence 
of having functional consequences (defined by a score 
<4); (ii) associated with an eQTL in cis and/or trans 
(ctQ); and (iii) associated with an meQTL in cis and/or 
trans (ctM). EAF, effect allele frequency of the pooled 
meta-analysis; β, effect size in the AFB and NEB 
analyses. All P values are from the sample-size-
weighted fixed-effects meta-analysis. (Barban et al., 
2016) 
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A gene-based approach using VEGAS (Liu et al., 2010) confirmed 7 loci from 
SNP-based GWAS for trait AFB and identified 3 new loci: SLF2, ENO4 and 
TRAF3-AMN. For NEB trait was confirmed the signal on gene GATAD2B and 
one new on chromosome 17. 
Causal variants 
In order to identify potentially causal variants in both analyses performed, the 
functional annotation showed non-synonymous SNPs in high LD with our 
significant variants on chr1 in gene CREB-regulated transcription co-activator 
2 (CRTC2) (rs11264680, r2=0.98) and CREB protein 3 like 4 (CREB3L4) 
(rs11264743, r2=0.94). This latter SNP is considered probably damaging and 
deleterious respect to PolyPhen and SIFT. CRTC2 gene is a mediator of FSH 
(follicle-stimulating hormone) and TGF-β1-stimulated steroidogenesis in 
ovarian granulosa cell (Fang et al., 2012); CREB3L4 is highly expressed in 
the ovaries, uterus, placenta, prostate, testis and has a role in male germ 
development (Adham et al., 2005). Our significant variant on chr3 is in LD with 
two nonsynonymous SNPs in MST1R gene (rs2230590, r2=0.95 and 
rs1062633, r2=0.95).  
An analysis with RegulomeDB (Boyle et al., 2012) identified, among the 
significant variants, 50 SNPs that might have functional consequences 
influencing downstream gene expression (supplementary Table 6 of Barban et 
al., 2016). In particular stand out two sets of SNPs, one on chromosome 1 (18 
SNPs) where the most promising variants, rs6680140, is located in a site of 
acetylation of histone H3 at lysine 27 near active regulation elements and 
another on chromosome 3 (25 SNPs) in a transcription factor binding site. 
Genes that bind one or more of 18 variants on chromosome 1 are CREBBP, 
HNF4A, CDX2 and ERG and they may act upstream in the causal pathway 
and influence the expression of causal genes at this locus. On chromosome 3, 
7 were eQTL for HYAL3 and 10 for RBM6 in monocytes. 
Other 2 variants on chromosome 3, rs2247510 and rs1800688, are in 
H3K27ac sites and DNA I hypersensitivity cluster. 
eQTL and meQTL analyses 
For the 12 independent lead SNPs, local (cis, exons or methylation sites <1 
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Mb from SNP) and genome-wide (trans, exons or methylation sites >5 Mb 
from SNP) effects were identified between SNP and exon/methylation sites. 
Whole-blood BIOS eQTL and methylation quantitative trait locus database 
were used for this analysis (Zhernakova, Deelen, Vermaat, Iterson, & Van, 
2015) (Bonder, Luijk, Zhernakova, & Moed, 2016). Seven SNPs were 
associated in cis with the expression of 54 genes and 5 are in high LD with 
the strongest eQTL for at least one gene in the corresponding locus: this 
means that the SNPs associated with NEB and AFB and the SNPs associated 
with expression tag the same functional site (supplementary Table 7 of 
Barban et al., 2016). 3 variants are associated with expression of 8 genes in 
trans (supplementary Table 8 of Barban et al., 2016). Also meQTL analysis 
that establish quantitative differences in DNA methylation between the two 
alleles show significant association: 11 of 12 lead SNPs are associated with 
DNA methylation of 131 genes in cis and 3 SNPs with 10 genes in trans. 
Functional network and polygenic prediction 
No enrichment in biological functions, neither genes and tissue sets were 
highlighted: this results reflect the need for a larger sample size but also 
because phenotypes are influenced by a mixture of biological, psychological 
and socio-environmental factors.  
The polygenic scores for AFB and NEB were calculated using PRSice 
(Euesden, Lewis, & O’Reilly, 2015) and sets of significant SNPs in the 
respectively meta-analysis. Then, a regression model was used to predict the 
same phenotypes in 4 independent cohorts: HRS, LifeLines, STR and 
TwuinsUK. The mean predictive power of the polygenic scores is 0.9% for 
AFB and 0.2% for NEB. These results, also if the power of the polygenic score 
is low, showed that an increase of 1 s.d. in the NEB polygenic score is 
associated with 9% decrease in the probability of women remaining childless. 
Signal associated with related traits and disease 
Signal on chromosome 2 and on chromosome 3 were already associated with 
educational attainment (Okbay et al., 2016), the locus on chromosome 5 with 
age at menarche (J. R. B. Perry et al., 2014), locus on chromosome 6 with 
age at first intercourse (Day et al., 2016). The SNPs in chromosome 3 are in 
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LD with rs2013208 (r2=0.81) already associated with HDL cholesterol (Global 
Lipids Genetics Consortium et al., 2013) and with rs7613875 (r2=0.81) 
associated with BMI (Locke et al., 2015). 
None of the associated variants are associated with age of menopause 
whereas rs9589, rs6803222 and rs9858889 on chromosome 3 are associated 
with age of menarche. 
NEB showed significant and negative genetic correlation with years of 
education and age at first sexual intercourse (Figure 23 blue bar). AFB 
showed significant e positive genetic correlation with age at menarche and 
menopause, with voice breaking, birth weight, age at first intercourse and also 
with years of education. Smoking, triglyceride levels, risk of diabetes and BMI 
were associated with a lower genetic risk having an increase of AFB (Figure 
27 red bar).  
 
Figure 27. Genetic overlap between AFB or NEB and other related traits. Results from LD Score 
regressions show estimates of genetic correlation with developmental, reproductive, behavioral, 
neuropsychiatric and anthropometric phenotypes for which GWAS summary statistics were available in 
the public domain. The lengths of the bars correspond to estimates of genetic correlation. Gray error 
bars represent 95% confidence intervals. An asterisk indicates that the estimate of genetic correlation is 
statistically significant after controlling for multiple testing (P < 0.05/27 = 1.85E10−3). (Barban et al., 
2016) 
 
In conclusion, the two most interesting loci in our analysis are located on 
chromosome 1 and 3: CRTC2 and CREB3L4 genes, that have non-
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synonymous variants in high LD with the lead SNPs, are critical signal 
mediators in follicle stimulating hormone and transforming growth factor β1 
stimulated steroidogenesis in ovarian the first whereas the second gene is 
high expressed in ovaries, uterus, placenta, prostate, testis and has a role in 
male germ cell development. Lead SNPs are associated with methylation 
status of these two genes and expression of CRTC2 in lymphocytes and 
whole blood. The association with other variants in locus on chromosome 1 
may be mediated by alterations in cAMP responsive element binding men and 
women. 
On chromosome 3, the lead SNPs rs2777888 is associated with the 
expression of RNF123 involved in cellular transition from quiescent to a 
proliferative state, it influences the expression of RNA-binding motif proteins 
(RBM5 and RBM6) that have role in cell cycle arrest, and it also affects the 
expression of LAMP2 on chromosome X. LAMP2 has a role in the acrosome 
reaction, allowing sperm to penetrate and fertilize ova, in fact encodes a 
lysosomal membrane protein (Tsukamoto et al., 2013). 
 
This work has permitted to identify coding and regulatory variants that are 
potentially causal and even if AFB and NEB are also subject to cultural and 
social environment, the analysis underlines the genetic factor that partly drive 
reproductive behaviors. 
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5. WGS INGI data 
As previously reported, whole genome sequencing was performed for a 
subset of 946 INGI individuals. 
After all filtering steps (see materials and methods – WGS INGI data), 926 
samples were retained. We identified approximately 27M sites (i.e. 
24,557,366 SNVs and 2,061,725 INDELs). 
Overall, 7.1 M sites (26%) were common (MAF>5%), 3.1M (12%) were low 
frequency (MAF between 1% and 5%) and 16.6M (62%) were rare (MAF 
<1%) with a partition similar in all cohorts. Singletons were >6M (24%) 
(6,193,486 SNPs and 273,679 INDELs) (Table 10).  
 
INGI All samples 
  CARL FVG VBI INGI 
Samples 124 378 424 926 
Average coverage 6.31 7.23 6.12 6.55 
Sites 13,370,262 17,002,010 19,361,094 26,619,091 
SNPs 12,208,629 15,521,313 17,830,208 24,557,366 
INDELs 1,161,633 1,480,697 1,530,886 2,061,725 
Sites MAF<=1% 3,627,622 7,283,720 9,416,028 16,685,951 
Sites 1%<MAF<=5% 3,007,162 3,069,534 3,121,545 3,125,971 
Sites MAF>5% 6,735,478 6,648,756 6,823,521 7,123,064 
Singletons SNPs 2,061,824 2,784,746 3,554,744 6,193,486 
Singletons INDELs 92,372 131,275 133,156 273,679 
Average singleton per sample 17,285 7,671 8,646 6,925 
 
Table 10. Number of variants shared or private in INGI population 
 
For each individual we identified on average ~3.5M variant sites including 
~0.56M indels and ~6.000 singletons.  
A comparison between INGI cohorts showed that about 50% of the called 
variants were shared among at least two populations while another 50% were 
private (Table 11, Figure 28).  
 
 Shared variants Private variants 
 COMMON VBI-CARL VBI-FVG FVG-CARL CARL only VBI only FVG only 
SNPs 9,045,896 721,758 1,834,514 354,720 2,086,255 6,228,040 4,286,183 
INDELs 886,471 69,417 213,110 53,191 151,822 359,316 325,779 
TOT 9,932,367 791,175 2,047,624 407,911 2,238,077 6,587,356 4,611,962 
 
Table 11. Number of variants shared or private in INGI population 
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Figure 28. INGI sites comparison 
 
Interestingly, most of the variants shared within INGI cohorts were found in 
the outbred references (~ 14 M in 1000 Genome project and ~15 M sites in 
UK10K) while most of the private ones remained private (>10 M with 1KG and 
>8M with UK10K). About 10% of the sites shared between two or all three 
populations, was not found in the EUR population or in UK10K dataset 
suggesting that they may be characteristics of the general Italian population. 
The majority of the private variants are within the range of low (MAF 1-5%) 
and rare frequencies (MAF < 1%). 
 
After the QC step an Italian reference panel with WGS data was built: a `core' 
INGI+TSI panel was created merging data from the different INGI cohorts with 
those from the TSI cohort from the 1KGP3 (INGI+TSI), using the method 
implemented by the IMPUTE2 software. 
We assessed the quality of INGI panel using two different parameters: the r2 
metric, which measures the correlation between the true genotype and the 
imputed genotype for the subset genotyped with commercial chips and the 
IMPUTE info score parameter, which provide a measure of the observed 
statistical information associated with the allele frequency estimate for each 
variant (Marchini & Howie, 2010). 
The usage of “ad hoc” reference panels permits to identify specific and rare 
variants for each study. 
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Loss of function and human knockouts 
In the final clean dataset of WGS INGI data, we focused the attention on Loss 
of Function (LoF) variants that might have different effects on genes: LoF may 
be maintained in a population because they have a mild effect or are in 
heterozygosity otherwise they could have a stronger effect on phenotype. 
Interestingly, some may be also found in homozygosity and can be defined as 
human Knock-out (hKO). Among the deleterious variants in the analyzed 
cohorts (See materials and methods - Human knockout), 506 presenting with 
a CADD score >20 (Kircher et al., 2014) were found in homozygous state in at 
least one individual, in one population. Stop gain variants have in average a 
higher CADD score (Figure 29). 
	
Figure 29. CADD score divided in functional categories 
 
Transcript analysis revealed that only 205 affected all transcripts in 195 
different genes. Among the 205 variants, the majority (150, 73%) were shared 
among all 3 populations (Figure 30). They span the entire spectrum of 
frequency but more than half (~60%) had frequency >=0.05. 
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Figure 30. Number of hKO shared among INGI population. 
 
Gene ontology analysis was useful to perform enrichment analysis on gene 
sets. The aim is also to identify if in our INGI population we have some KO 
gene involved in fertility. 
The analysis revealed an excess of olfactory receptors hKO, several of the 
hKOs are located in genes involved in hair/skin/epithelium or eye phenotypes, 
and many members of gene families. In these categories KO may not cause a 
phenotypic effects because their possible function may be replaced by 
another gene of the same family and especially for OR could become a 
pseudogene (humans have approximately 400 functional genes coding for 
olfactory receptors, and other 600 candidates are pseudogenes). 
Common human knockout could have been maintained because they may 
have beneficial effects, such as a stop gain (rs497116 Arg/X) in CASP12 
associated with resistance to infection and sepsis (Saleh et al., 2004). 
Indeed, rare hKO could have a phenotypic effect: we identified a frameshift 
that cause KO of GnRH-II gene (Gonadotropin-Releasing Hormone 2) 
correlated with fertility. 
GnRH2 knockout 
In mammals gonadotrophin-releasing hormone I and the type I GnRH 
receptor drive the reproductive hormonal cascade in mammals: stimulate 
synthesis and secretion of luteinizing hormone (LH) and follicle stimulating 
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hormone (FSH). Mammals have a second hormone and receptors called 
GnRH-II system but in many species, one or both genes of GnRH-II are 
disrupted. Humans have only a gene encoding GnRH-II but no the functional 
receptors (Stewart, Katz, Millar, & Morgan, 2009). Human GnRH-II contains 
four exons, the first of which is non coding. From literature we known that 
different disruptive mutation appears within mammalian in GnRH-II genes 
(Table 12) and they cause gene knockout. 
 
	
Table 12. Disruptive mutations within mammalian GnRH2 genes (Stewart et al., 2009). 	
We identified a frameshift (rs16996832: insertion of GCCC - E/EPX) in GnRH-
II in homozygous state in 38 INGI samples (respectively 22 in VB, 14 in FVG 
and 2 samples in CARL) with a frequency of 0.18 from INGI cohort and 0.10 
in European population of 1000 Genome. Individuals with this mutation in 
homozygosity have GnRH-II KO rendering their product non-functional but 
also do not show any particular phenotypes since GnRH-I system is driving 
the reproductive hormonal cascade. This example shows no effect cause from 
KO due to the redundancy of function from another gene of the same family. 
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6. Quantitative AMH GWAS with WGS INGI samples 
A GWAS on quantitative trait Anti Müllerian hormone (AMH), a marker of 
ovarian reserve, was performed on INGI women. 475 women with less than 
41 years were included in analysis (244 from VB cohort, 152 from FVG and 79 
from CARL). 
We performed the analysis with data imputed with 2 different reference 
panels: the first analysis with 1000G phase1 (1000GP1) panel and the second 
with Italian reference panel (see WGS INGI data). 
Due to the small number of women that respect all the criteria of inclusion 
(see material and methods), analysis has only suggestive signal that no reach 
the threshold of significance.	
Interesting, in the comparison of both analysis, is evident the enrichment of 
variants with lowest p-value in signals with data imputed with Italian reference 
panel (Figure 31). 
The signal on chromosome 5 is in an intergenic region and is enriched in 
rare variants as reported in table 13. In this locus rare variants are better 
imputed with Italian reference panel in comparison to 1000GP1 imputation 
and they reach a suggestive p-value.  
 
Table 13. Suggestive signals in AMH GWAS with data imputed with Italian reference panel, chr 5. 
 
RS id chr pos A1 A2 Effect P-value Dir freq vb 
freq 
fvg 
freq 
carl 
info 
Italian 
info 
1000G 
rs12655444 5 81853493 C T 1.38 4.38E-06 +++ 0.01 0.02 0.01 0.923 0.879 
rs74354356 5 81855591 A AG -1.35 2.46E-06 --- 0.01 0.02 0.01 0.943 - 
rs78788723 5 81856711 A C -1.38 1.30E-06 --- 0.01 0.02 0.01 0.927 0.912 
rs79107879 5 81856874 T C -1.40 2.16E-06 --- 0.01 0.02 0.01 0.929 0.945 
rs75757001 5 81861862 G A 1.37 3.07E-06 +++ 0.01 0.02 0.01 0.935 0.851 
rs114906912 5 81864971 C T 1.36 3.75E-06 +++ 0.01 0.02 0.01 0.924 0.836 
rs10514241 5 81868187 T G -1.36 3.44E-06 --- 0.01 0.02 0.01 0.932 0.851 
rs75983158 5 81869241 A C -1.35 3.63E-06 --- 0.01 0.02 0.01 0.920 0.843 
rs12655100 5 81870579 A G -1.38 2.75E-06 --- 0.01 0.02 0.01 0.926 0.822 
rs16899734 5 81872254 C G -1.43 1.61E-06 --- 0.01 0.02 0.01 0.915 0.811 
rs78460703 5 81873459 C G -1.42 1.65E-06 --- 0.01 0.02 0.01 0.915 0.809 
rs57253569 5 81876751 T A 1.44 1.46E-06 +++ 0.01 0.02 0.01 0.917 0.783 
rs78135984 5 81881180 C T 1.49 7.14E-07 +++ 0.01 0.02 0.01 0.867 0.753 
rs74291681 5 81881336 T C -1.47 1.10E-06 --- 0.01 0.02 0.01 0.903 0.745 
rs2385889 5 81882497 A G -1.51 5.92E-07 --- 0.01 0.02 0.01 0.884 0.721 
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On chromosome 12 we have a very similar scenario: the signal is enriched in 
variants better imputed with Italian reference panel (Table 14), 15 variants in 
this locus reach the suggestive limit.  
 
RS id chr pos A1 A2 Effect P-value Dir freq vb 
freq 
fvg 
freq 
carl 
info 
Italian 
info 
1000G 
rs61930911 12 86288138 A G -0.37 2.72E-06 --- 0.22 0.22 0.22 0.993 0.990 
rs7301600 12 86289984 G C 0.41 2.05E-06 +++ 0.16 0.16 0.19 0.994 0.987 
rs73177142 12 86290735 C T 0.37 2.43E-06 +++ 0.21 0.22 0.22 0.992 0.988 
rs61930913 12 86291121 G A 0.37 2.07E-06 +++ 0.22 0.22 0.22 0.994 0.987 
rs11117088 12 86291542 G T 0.41 1.88E-06 +++ 0.16 0.16 0.19 0.994 0.987 
rs4143239 12 86291728 T A 0.37 2.07E-06 +++ 0.22 0.22 0.22 0.994 0.987 
rs10863094 12 86292351 C T 0.37 2.07E-06 +++ 0.22 0.22 0.22 0.994 0.987 
rs79932392 12 86292574 GCTA G -0.37 2.07E-06 --- 0.22 0.22 0.22 0.994 - 
rs2897186 12 86293716 G A 0.37 2.06E-06 +++ 0.22 0.22 0.22 0.994 0.987 
rs11117089 12 86294163 T C -0.37 2.06E-06 --- 0.22 0.22 0.22 0.994 0.987 
rs58780912 12 86296085 G A 0.42 1.78E-06 +++ 0.16 0.16 0.19 0.994 0.986 
rs11609918 12 86297970 A G -0.42 1.44E-06 --- 0.16 0.16 0.19 0.988 0.987 
rs11117093 12 86302072 A T -0.41 2.50E-06 --- 0.16 0.15 0.19 0.995 0.987 
rs11117097 12 86303286 A G -0.41 2.48E-06 --- 0.16 0.15 0.19 0.996 0.976 
rs12313362 12 86304321 A G -0.41 2.46E-06 --- 0.16 0.15 0.19 0.996 0.987 
 
Table 14. Suggestive signal in AMH GWAS with data imputed with Italian reference panel on chr 
12. 
Signal on chromosome 19 is on gene PPP5C and for each variant with a 
suggestive p-value the functional consequences is reported in table 15. 
PPP5C gene encodes a serine/threonine phosphatase, which is a member of 
the protein phosphatase catalytic subunit family. In literature is reported that 
the product of this gene participate in signaling pathways in response to 
hormones or cellular stress, and elevated levels of this protein may be 
associated with breast cancer development [provided by RefSeq, Feb 2011]. 
The last suggestive signal is on chromosome 22, on gene POLDIP3; 8 
variants (5 are intron variants, 1 is an upstream gene variant and 1 is a 
missense variant) have suggestive p-value in Italian reference panel and 
these variants are better imputed in comparison with 1000GP1 imputation 
(Table 15). POLDIP3 encodes an RRM (RNA recognition motif)-containing 
protein that participates in the regulation of translation by recruiting ribosomal 
protein S6 kinase beta-1 to mRNAs. RPKM (Reads Per Kilobase Million) 
analysis, quantifying gene expression from RNA sequencing data, shows a 
ubiquitous expression of POLDIP3 in ovary (RPKM 49.2) (Figure 32). 
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Figure 31. SNPs are plotted on the x axis according to their position on each chromosome 
against association with AMH (A) with data imputed to 1000G phase I and (B) with data imputed 
with Italian reference panel. The solid blue line indicates the threshold for genome-wide significance 
(P < 5 × 10−8), and the red line represents the threshold for suggestive hits (P < 5 × 10−6). Signal 
encircled in green improve in data imputed with Italian reference panel. 		 	
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Table 15. Suggestive signals in AMH GWAS with data imputed with Italian reference panel. Signal 
on chr 19 and on chr 22 		
		
Figure 32. Analysis RPKM (Reads Per Kilobase per Million mapped reads), a method of quantifying 
gene expression from RNA sequencing data by normalizing for total read length and the number of 
sequencing reads, for gene POLDIP3. 
RS id chr pos A1 A2 Effect P-value Dir freq vb 
freq 
fvg 
freq 
carl 
info 
Italian 
info 
1000G cons 
rs16980461 19 46856133 G A 0.56 3.53E-06 +++ 0.08 0.07 0.08 0.991 0.973 intron 
rs917948 19 46857015 C T 0.56 4.50E-06 +++ 0.08 0.07 0.08 0.987 0.968 synonymous 
rs917946 19 46860058 A G -0.57 3.00E-06 --- 0.08 0.07 0.08 0.991 0.975 intron 
rs55842357 19 46863135 C T 0.57 2.93E-06 +++ 0.08 0.07 0.08 0.991 0.957 intron 
rs2239380 19 46870302 T C -0.61 5.61E-08 --- 0.09 0.08 0.09 0.991 0.975 intron 
rs56203900 19 46888566 C T 0.59 1.19E-07 +++ 0.09 0.08 0.09 0.990 0.980 intron 
rs73043492 19 46888894 G A 0.55 4.93E-06 +++ 0.08 0.07 0.08 0.994 0.979 intron 
rs58701793 19 46890247 G C 0.60 1.04E-07 +++ 0.09 0.08 0.09 0.995 0.989 intron 
rs8811 19 46893810 G A 0.61 5.48E-08 +++ 0.09 0.08 0.09 0.997 0.996 3_prime_UTR 
rs741231 19 46894163 C A 0.61 5.25E-08 +++ 0.09 0.08 0.09 0.997 - downstream 
RS id chr pos A1 A2 Effect P-value Dir freq vb 
freq 
fvg 
freq 
carl 
info 
Italian 
info 
1000G cons 
rs66748203 22 42999394 D A -0.43 3.23E-06 --- 0.12 0.14 0.14 0.995 - intron 
rs137108 22 43002362 A G -0.46 9.48E-07 --- 0.12 0.14 0.13 0.982 0.986 intron 
rs146980368 22 43003683 G A 0.45 1.47E-06 +++ 0.12 0.14 0.13 0.985 0.970 intron 
rs148867399 22 43003771 A G -0.44 2.50E-06 --- 0.12 0.14 0.14 0.996 0.974 intron 
rs137110 22 43007597 A C -0.44 2.45E-06 --- 0.12 0.14 0.14 0.996 0.986 intron 
rs137113 22 43009817 G C 0.44 2.32E-06 +++ 0.12 0.14 0.14 0.997 0.986 intron 
rs28627172 22 43010817 G A 0.45 8.51E-07 +++ 0.13 0.14 0.14 0.999 0.974 missense 
rs137114 22 43011246 C T 0.44 2.13E-06 +++ 0.12 0.14 0.14 0.997 0.979 upstream 
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An analysis with Variant Effect Predictor (VEP) (McLaren et al., 2016) for 
variants with suggestive p-value in AMH GWAS imputed with Italian reference 
panel showed that the majority are intron variants, no one have high effect, 
there is only 1 missense with moderate effect in POLDIP3 (Figure 33).  
 
 
Figure 33. Functional consequences of suggestive variants of AMH GWAS according to VEP. 
 
PANTHER pathway analysis showed a significant result emphasize in yellow 
in figure 34 and table 16. DNA replication pathway has a fold enrichment of 
46.97 with p-value of 2.18E-2. Panther “DNA replication” pathway includes a 
series of integrated protein-protein and protein-DNA interactions and 
enzymatic reactions to ensure high accuracy of DNA replication. 
 
Homo 
sapiens
 (REF) 
upload_1 
PANTHER 
Pathways 
n° 
genes n° genes expected 
Fold 
Enrichment +/- 
raw P 
value 
DNA replication 28 1 0.02 46.97 + 2.18E-02 
EGF receptor 
signaling pathway 135 1 0.1 9.74 + 9.85E-02 
Cadherin signaling 
pathway 148 1 0.11 8.89 + 1.07E-01 
Gonadotropin-
releasing hormone 
receptor pathway 
227 1 0.17 5.79 + 1.60E-01 
 
Table 16. PANTHER Overrepresentation Test (Released 20171205). Annotation Version and Release 
Date: PANTHER version 13.0 Released 2017-11-12. Reference List: Homo sapiens all genes in 
database. Analyzed List: upload_1 (suggestive gene in AMH GWAS with Italian reference panel) 
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Figure 34. PANTHER Overrepresentation Test (Released 20171205). Annotation Version and 
Release Date: PANTHER version 13.0 Released 2017-11-12. Reference List: Homo sapiens all genes 
in database. Analyzed List: upload_1 (suggestive gene in AMH GWAS with Italian reference panel). 
Only a part of results are showed. 
 
In conclusion, even if the sample size is very small in our AMH GWAS, we 
found “DNA replication” pathway enriched in our suggestive signal and a 
signal on gene POLDIP3, involved in regulation of translation, overexpressed 
in the ovary. 
We demonstrate the improvement of imputation quality with Italian reference 
panel in comparison with 1000G phase I panel, especially for rare variants. 
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7. Fertility preservation in endometriosis patients: is AMH 
a reliable marker of the ovarian follicle density? 
(Garavaglia et al., 2017) 
In our study we have evaluated pre-surgical serum AMH levels in a cohort of 
endometriosis patients undergoing ovarian cortex resections for fertility 
preservation at San Raffaele Hospital in Milan in the years 2011–2014, 
compared to a large control group, and then we have tested the hypothesis 
that the preoperative AMH values may correlate with the individual follicular 
density. 
 
A statistical analysis on AMH values of 201 untreated endometriosis patients 
and 387 normal women shows that the median of AMH residual levels is 
significantly lower in cases compared to controls (P=1.0x10-3) and the 
significance increase when the threshold of >36 years was applied (in women 
with >36 years there was a depletion of ovarian reserve) with a p-value of 
2.7x10-4. In summary, AMH decreased as expected in all women, but the 
decrease was faster in endometriosis cases (Fig. 35) 
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Figure 35. Multiple regression analysis of AMH and age. Scatter plot of the correlation between AMH 
residues and age in cases (solid circles) and controls (solid triangles). Linear interpolation for cases 
(solid lines) and controls (dashed lines) together with confidence intervals (gray shadowed area) are 
reported. (Garavaglia et al., 2017) 
Ovarian biopsies were collected in a subset of 24 endometriosis cases and 33 
controls. In this samples the number of primordial follicles decreased 
significantly with age as expected, but this decrease did not show any 
significant differences between case and controls in this study, even if we 
consider only older cases (>36 years). 
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Figure 36: Histological analysis of cortical ovarian strips. (a) Hematoxylin/ eosin staining shows 
primordial, early, and mature primary follicles of one representative ovarian cortical strip of a control 
(125×). (B) Hematoxylin/eosin staining shows a few primordial follicles (severe ipotrophia for age of the 
patient) in a fibrosclerotic tonaca albuginea of one representative cortical strip of an endometriosis 
patient (200×). (Garavaglia et al., 2017) 
We confirmed a statistically significant correlation between AMH serum levels 
and the number of primordial follicles with a regression analysis adjusted for 
age, kit and laboratory test kit. The estimated effect (beta value) of the 
regression curve was higher in endometriosis patients, suggesting a faster 
depletion of primordial follicles in cases. 
We underlines the importance to measure AMH levels in women with 
endometriosis in order to consider a cryopreservation before the accelerated 
follicular depletion during disease progression. 
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INGI genotyping and imputation 
Val Borbera samples 
1664 samples were genotyped with Illumina 370K Quad v3 chip and 
additional 121 samples with Illumina 700K Omni Express array.  
Imputation was performed with software IMPUTE2 (Howie, Marchini, & 
Stephens, 2011) after SNP filtering; SNPs with minor allele frequency < 1%, 
Hardy‐Weinberg p‐value < 10‐6, call rate < 0.9 were removed. The panel for 
imputation used was the 1000G Phase I Integrated Release Version 3 
[MARCH 2012]. 
1786 VB samples were genotyped with Human Exome 12v1-2_A chip. After 
variants calling with software Zcall (Goldstein et al., 2012), different filters 
were applied for QC (HWE>=10-6 (applied only to common SNPs with 
MAF>5%), CALLRATE >= 95 and MIND >= 95%) and a subset of 1779 
samples with 243,961 markers genotyped was obtained. 
Friuli Venezia Giulia samples 
1696 samples were genotyped: 1330 with llumina 370K Quad v3 chip and 
additional 366 samples with Illumina 700K Omni Express array. 1913 samples 
were also genotyped with HumanExome and with Illumina Omni Express 
Exome array. For the analysis people with age < 18 were excluded. Different 
filter of quality were applied: sample call rate 95%, HWE>=10-6, SNP call rate 
99%. 
Carlantino samples 
630 samples were genotyped with Illumina Infinium Duo and Infinium Quad 
chip and 820 also with exome chip Illumina Omni Express Exome array. 
People with age <18 were excluded for the analysis and quality filter were 
applied before analysis: sample call rate 95%, HWE>=10-6, SNP call rate 
99%. 
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1. Rare coding variants and X-linked loci associated with age 
at menarche. (Lunetta et al., 2015) 
GWAS age at menarche on exome array 
A linear regression model on age at menarche between age 9 and 17, 
adjusted for birth year and principal component was used in each study 
performed, using the skatMeta/seqMeta package in R. Variants with MAF>5% 
in the meta-analysis were excluded. SKAT test assume that rare variant 
effects are random and can contain risk, protective or null rare alleles. 
A burden test was performed using seqMeta, a gene-based test, for low-
frequency variants, which assume that the entire set of rare variants have the 
same effect direction. Only a first subset of variants with MAF<1% and 
separately other subsets for all non-synonymous annotated as ‘damaging’ 
and for loss of function, were used in both tests. Study significance threshold 
was calculated including 2 tests x 3 filters x number of genes (P<1.14 x 10-6).  
Meta-analysis was performed with software METAL (significance threshold 
P<5 x 10-8). Follow-up was run on 2 different groups of women: 76,831 from 
23andME with exome array available and 39,486 from deCODE study with 
imputation data available. Variants of both studies had passed genotyping QC 
or imputation quality score > 0.4. 
GWAS age at menarche on X chromosome 
76,831 women from 23andME study of European ancestry provided informed 
consent to participate in the analysis. SNPs with HWE < 10-20, call rare < 95% 
or with large difference in frequency compared to 1000G were removed. 
Genotype data were imputed against the 1000G reference panel march 2012 
‘v3’ release. A linear regression model assuming additive allelic effects was 
performed and women from deCODE were used as replication. 
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2. Genomic analyses identify hundreds of variants 
associated with age at menarche and support a role for 
puberty timing in cancer risk. (Day et al., 2017) 
GWAS age at menarche imputed to 1000G 
Each study performed an additive linear regression model for association with 
AAM, using as covariates age at visit and other specific for each population 
for example PCA. Data were imputed to 1000 Genome Project reference 
panel and a standardized quality control pipeline was applied at study-level. 
Software METAL was used for meta-analysis: first ReproGen consortium 
studies were combined and only SNPs present in over half of studies were 
taken forward and secondly ReproGen data were combined with UK Biobank 
and 23andMe studies. Variants with combined MAF>0.1% were analyzed and 
using a distance-based metric (any SNPs passing the significance threshold 
within 1 MB of another significant SNP were considered to be located in the 
same locus) a list of index variants was defined. 
39,486 women from deCODE study was used as replica. 
Parent-of-origin-specific associations and variance 
Women from deCODE study with parental origins of alleles determined by a 
combination of genealogy and long-range phasing was used to study parent-
of-origin-specific allelic associations. 
The variance explained by each associated variant was calculated with the 
following formulas where f is MAF, fh is homozygous frequency of the variant 
and β is the effect of specific model:  
additive model 2 f (1-f) βa2  
recessive model fh (1-fh) βr2  
maternal model f (1-f) βm2 
paternal model f (1-f) βp2 
Variance explained across multiple SNPs was calculated summing the 
variance of the single variants. 
Mendelian randomization analyses 
Mendelian randomization analyses was performed in order to understand if 
there is a causal effect of puberty timing on the risks of cancer sex-steroid-
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sensitive. In Mendelian randomization, the basic principle utilized is that 
genetic variants that alter the level or mirror the biological effects of a 
modifiable environmental exposure that itself alters disease risk should be 
related to disease risk to the extent predicted by their influence on exposure 
to the environmental risk factor (George Davey Smith and Shah Ebrahim). 
Genotyped data of individuals with cancer were available thanks to Breast 
Cancer Association Consortium (BCAC), Endometrial Cancer Association 
Consortium (ECAC) and Ovarian Cancer Association Consortium (OCAC). 
Genetic variants predicted AAM was tested in a logistic regression model for 
association with each cancer.  
A BMI-adjusted analysis was performed including AAM genetic risk score as a 
covariate. 
Pathway analyses 
A gene set enrichment analysis (GSEA) implemented in MAGENTA (Meta-
Analysis Gene-set Enrichment of variaNT Associations) software was 
performed (Ayellet et al., 2010). The aim is to test for enrichment of genetic 
associations in predefined biological processes or sets of functionally related 
genes. For each gene, a single index SNP with the lowest p-value, within 
110kb upstream and 4kb downstream of gene mapped in the genome, was 
considered and analysis give a gene score corrected for confounding factors 
such gene size and SNP density. The number of scores in a given pathway 
were ranked and then compared to 1,000,000 randomly permuted pathway of 
the same size. An empirical GSEA p-value was created for each pathway. 
Gene expression data integration 
A LD score regression to specifically expressed gene (LDSC-SEG) was 
performed to identify tissue and cell types most relevant to gene associated 
with AAM. This approach uses stratified LD score regression to test whether 
disease heritability is enriched in regions surrounding genes with the highest 
specific expression in a given tissue (Finucane et al., 2017). Genes were 
ranked by a t-statistic for differential expression for each tissue and the 
contribution of the annotation of the top 10% of genes by this ranking were 
estimated. 
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To identify specific eQTL-linked gene both summary Mendelian randomization 
(SMR) and MetaXcan was performed. The first approach was run against 
whole-blood eQTL available data set by Westra to map potentially functional 
genes to trait-associated SNPs. The second approach is a meta-analysis 
extension of the PrediXcan that incorporates information from gene 
expression and GWAS data to translate evidence of association with a 
phenotype from SNP level to the gene. Gene expression information was 
taken from the GTEx project: DNA and RNA from multiple tissues were 
sequenced from almost 1,000 European, African and Asian dead individuals. 
MetaXcan in this analysis were targeted to tissue with previous evidence of 
association with AAM. 
3. Large-scale genomic analyses link reproductive aging to 
hypothalamic signaling, breast cancer susceptibility and 
BRCA1-mediated DNA repair. (Day et al., 2015) 
GWAS age at menopause on all genome 
A total sample size of 69,360 individuals of European descent (33 studies) 
was collected for GWAS on age at natural menopause. Data were imputed to 
HapMap2 panel and for the cohort with data imputed to 1000 Genome project 
were take into consideration only SNPs included in HapMap2. GWAS was 
performed for each cohort separately and an additive model including top 
principal components and study-specific covariates was run. Quality controls 
were applied: SNPs with MAF < 1% and imputation quality <0.4 were 
removed. Meta-analysis was performed with METAL using an inverse 
variance-weighted. Only SNPs that had data from more than 50% of the 
studies were considered for results and the cut off of significant pvalue was 
applied according to Bonferroni correction (P < 5x10-8). 
GWAS age at menopause on exome chip data 
Twenty-two studies of European ancestry performed R package skatMeta or 
seqMeta analysis with exome genotyping data available on autosomal and on 
X-chromosome. A single-variant meta-analysis was performed in METAL with 
a total sample size of 39,026; the cut off of significance was set to P< 5x10-8 
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according to Bonferroni correction. Replication was performed in the deCODE 
study (n=10,157). 
Conditional analysis 
GCTA software package was used to identify independent signals. LD 
between variants was estimated in genotype of 3 different studies: Rotterdam 
study I (n=5,974) and 2 EPIC-InterAct data set (n=7,397 and 9,294). We 
assumed zero correlation between SNPs more than 10Mb apart. 
The independence of the exome array and HapMap2 signals was confirmed 
with a conditional analysis in the Women’s Genome Health study (n=11,664). 
Regression analysis including all significant index SNPs in additive model was 
performed. 
Causative gene identification 
The likely causative genes were annotated selecting genes identified by 
GRAIL (Raychaudhuri et al., 2009) or STRING programs (Szklarczyk et al., 
2015), genes in which the top SNP was a coding variants or in an eQTL. 
GRAIL program suggests the most likely causal gene at each locus and a P< 
0.05 was taken to indicate a suggested causal gene. 
Pathway identification 
Several softwares were used to test for signal enrichment: Panther, Ingenuity, 
GO, KEGG, Reactome and Biocarta using MAGENTA (Ayellet et al., 2010). 
We also tested 4 custom pathways for gene involving in age at menarche 
(n=154), ovarian function (n=130), POI (n=31) and monogenic disorders of 
puberty (n=21). 
Estimating variance  
Restricted maximum likelihood (REML) implemented in GCTA was used to 
estimate the total variance explained by ANM-associated SNPs. Variance was 
calculated at varying significance thresholds (5x10-7, 5x10-6, 5x10-5, 5x10-4, 
0.005, 0.05 and all SNP passing the quality control). 
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4. Genome-wide analysis identifies 12 loci influencing human 
reproductive behavior. (Barban et al., 2016) 
GWAS reproductive behavior 
Sixty-two cohorts participated to the analysis of two traits regarding human 
reproductive behavior: age at first birth (AFB) and number of children ever 
born (NEB). GWAS was performed on data imputed to HapMap 2 CEU. In the 
analysis only people with European ancestry and with all covariates data were 
included: sex, age of birth and cohort-specific covariates. An additive linear 
model with the entire set of covariates was performed for each cohort and a 
QC protocol, similar of the GIANT consortium‘s QC used in the recent study of 
human height (Wood et al., 2014), was utilized to verified the quality of 
analysis. Sample-size weighted meta-analysis was performed with software 
METAL in which only variants in at least 50% of the participants for a given 
phenotypes were included. Sample size of meta-analysis reaches 251,151 
individuals for AFB pooled and 343,072 for NEB pooled. Meta-analyses were 
performed also divided by sex: 189,656 women and 48,408 men for AFB and 
225,230 women and 103,909 men for NEB. 
The lead SNPs for each significant locus was identified with the PLINK 
clumping function (Chang et al., 2014). 
A gene-based analysis was performed with VEGAS (Mishra & Macgregor, 
2015): a 50kb extra window surrounding the genes were considered in the 
analysis. 
Functional variant analysis using RegulomeDB 
RegulomeDB (Boyle et al., 2012) integrates results from ENCODE project (E. 
N. C. O. D. E. P. Consortium et al., 2012) and Roadmap Epigenomics project 
(R. E. Consortium et al., 2015). 322 significantly associated SNPs (P< 5x10-8) 
with AFB and/or NEB in meta-analysis were tested and those with 
RegulomeDB score < 4 were considered been functional and analyzed in 
details regards eQTL and their protein-binding capacity. 
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eQTL and meQTL analyses. 
Spearman’s rank correlations between SNPs and local or global 
exons/methylation sites were computed for lead SNPs in GWAS to identified 
the possible local (cis, exons/methylation sites < 1 MB from the SNP) and 
genome-wide (trans, exons/methylation sites > 5 MB from the SNP) effects. 
LD between strongest eQTLs identified for these exons/methylation sites and 
the corresponding SNP identified in the GWAS were computed using BIOS 
genotypes. The BIOS consortium used samples from five Dutch cohorts: The 
Leiden Longevity Study (Deelen et al., 2014), The Rotterdam Study (Ho fman 
et al., 2009), The LifeLines-DEEP cohort (Tigchelaar et al., 2015), The Cohort 
on Diabetes and Atherosclerosis Maastricht (CODAM) (Van Dam, Boer, 
Feskens, & Seidell, 2001) and The Netherlands Twin Register (Willemsen et 
al., 2013). Bonferroni multiple testing correction was performed for the 12 
SNPs tested.  
Gene prioritization 
All genes located within 40 kb of the lead SNPs were used as input for four 
bioinformatics tools in order to identify potentially causal genes: ToppGene 
(Chen et al., 2009), Endeavor (Tranchevent et al., 2008), MetaRanker (Pers 
et al., 2013) and DECIPT (Pers et al., 2015). For the first three softwares a list 
of genes with a role in fertility was used as training (BRCA1, EGFR, ERBB2, 
ERBB3, ERBB4, HSD17B1, RBM5, ESR1, ESR2 and FSHB). MetaRanker 
use SNPs that reached P<5x10-4 and their chromosomal position as input. We 
performed a gene prioritization procedure using also software DECIPT giving 
as input all meta-analysis SNPs that reached P<5x10-4. 
Functional network enrichment 
To identified gene set, tissue and cell type enrichment among the variants 
with p-value less than 5 x 10-4 in meta analysis, DECIPT software was used 
(Pers et al., 2015). DEPICT was only able to perform analyses for AFB and 
NEB pooled, and AFB women due to the number of samples. 5 prioritized 
candidate gene sets were combined for the analysis: closest genes to the 
lead SNPs, closest genes to the non-synonymous SNPs in high LD (r2>0.50) 
with the corresponding lead SNP, closest genes to other types of SNPs in 
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very high LD (r2>0.80) with the corresponding lead SNP, and expression 
probe gene names of cis, and trans eQTLs. 
Polygenic score prediction 
Polygenic scores were calculated for AFB and NEB, based on GWA meta-
analysis results and using regression models to predict the same phenotypes 
in four independent cohorts: HRS, Lifelines, STR and TwinsUK. Polygenic 
scores for NEB were tested to predict childlessness at the end of the 
reproductive period (using age 45 for women and 55 for men). Finally, we also 
tested the predictive value of our polygenic scores for AFB for age at 
menarche (using TwinsUK) and age at menopause (using Lifelines). 
5. WGS INGI DATA 
Genotype calls for autosomal chromosomes were separately produced for 
each population, data were annotated using bcftools (v.1.2) to add information 
about Ancestral Allele and allele frequencies from 1000GP phase 3 (1KGP3) 
populations and rsIDs from dbSNP v.141. Furthermore functional annotations, 
Polyphen and Sift information’s and CADD score were added.  
Very stringent filters were applied for quality check both by samples and by 
site. Individuals with excess of singletons (> than 60000 singletons: one 
sample from the FVG cohort) and excess of heterozygosity (> than 3 SD of 
the mean: one from the CAR cohort, one from the FVG cohort and 4 samples 
from the VBI cohort) were removed from the analysis. Individuals with a Non-
Reference Discordance Rate (NRDR) greater than 5% were also removed 
(i.e. 8 samples from CAR, 1 from FVG and 5 from VBI cohort).  
Sites with Hardy-Weinberg equilibrium exact test p-value below the threshold 
of 1x10-8 and heterozygosity rate greater than 3 standard deviations of the 
mean were removed. For variants overlapping SNP array data available for 
each cohort, the Concordance and the Non-Reference Discordance Rate 
(NRDR) were calculated. Sites falling outside the boundaries of 3 standard 
deviation of the mean (5552, 2577 and 2502 sites from CAR, FVG and VBI 
respectively) were removed.	
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Human knockout 
To identify hKO we considered only deleterious variants in protein coding 
genes: we first selected variants with high impact as defined by VEP 
(McLaren et al., 2016) (i.e. frameshift, splice acceptor variant, splice donor 
variant, stop gained, stop lost, start lost, transcript ablation, transcript 
amplification) and among those we further selected for CADD score >=20. A 
total of 12,231 variants (8832 SNV and 3399 indels) were selected and 5,916 
had a CAD score >=20. Among the variants those presenting at least one 
homozygous individual in one population were defined putative hKO. After 
filter application, the average number of hKO per individual was 20 (12-31), in 
agreement with previous determinations (Vagheesh M Narasimhan et al., 
2016). 
6. GWAS ON AMH QUANTITATIVE TRAIT 
Women with less than 41 years, without any kind of ovaries surgeries were 
included in GWAS analysis performed with software GEMMA (Zhou & 
Stephens, 2014). AMH trait was normalized with square root and age, BMI 
and smoke behaviours were used as covariates. Analysis was performed both 
with data imputed to 1000G phase I and with Italian reference panel. Data 
were filtered to 0.4 for info quality of imputation and for MAF < 1%. Manhattan 
plot was performed in R language with qqman package (source qqman R 
packages). Variants were analysed with VEP (McLaren et al., 2016) for 
functional categories and a gene ontology analysis was performed with 
Panther (source PANTHER). 
7. Fertility preservation in endometriosis patients: is AMH a 
reliable marker of the ovarian follicle density? (Garavaglia 
et al., 2017) 
Human subject 
A totoal of 202 women in premenopausal period with endometriosis 
undergoing surgery for the first time were included in the study. The mean 
MATERIALS	AND	METHODS	
	 83	
age of women was 34.7 ± 5.9 years (19-48 age range). The day before 
surgery AMH dosage was performed. 
From a subgroup of 25 patients, ovarian biopsies were collected with micro-
scissors with cold blade from healthy ovarian cortex, far from the cyst. Tissue 
samples of about 4x4 mm were transferred to the pathology laboratory in 
formaldehyde. Biopsies from 33 patients undergoing surgery for different 
cause from endometriosis were used as control. 
A set of 200 women randomly selected from Val Borbera isolate population 
and other 200 from a cohort undergoing ART for male infertility at the 
Obstetrics and Gynecology Unit at San Raffaele Scientific Institute were used 
as controls for serum AMH dosage. 
Hormone assay 
Different immunoenzymatic assay kits were used for AMH serum levels: the 
GenII ELISA (Beckman Coulter) and the EIA AMH/MHS kit (Immunotech, 
Beckman Coulter). The limit of detection (LOD) of both assays was 0.14 
ng/ml. 
Tissue Preparation and Follicle counts 
All sections of biobsies were stained with hematoxylin and eosin and analyzed 
using an Olympus microscope at 200× magnification. According to Gougeon’s 
protocol (1986) we defined the developmental stages of follicles: the 
primordial follicle is a structure containing the primary oocyte surrounded by a 
single flat cells stratum, while the primitive follicle is an element assembled by 
the primary oocyte surrounded by the zona pellucida and by 1–2 cubical cells 
of the granulosa tissue. The follicle density was determined by dividing the 
number of follicles counted in 10 non-adjacent fields of 1 mm2 each by the 
volume of tissue analyzed (0.5 mm3). 
Statistical analysis 
Statistics analyses were performed in R 3.1.1 (source R Project for Statistical 
Computing) for analyzing follicles counts and the levels of AMH in the total 
sample (N = 602). Outlier values were excluded using a 3 SD threshold based 
on Shapiro–Wilk normality tests assessing the normality of the distributions. 
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We analyzed 588 AMH serum levels in 201 endometriosis cases and 387 
controls and 57 follicle counts in 24 cases and 33 controls after outliers 
exclusion. Normality Shapiro-Wilk test failed, so follicle counts were square 
root transformed whereas AMH dosage was transformed with a rank-based 
inverse normalization using the quantile R function qnorm (p, µ, σ). The 
continuous distributions of each transformed trait were represented by 
density() R function. The R wilcox.test() function and/or t.test() function were 
used to estimate significant difference in the median and/or mean of 
case/control population. The glm() R function was used to fit generalized 
linear models in regression analyses. ggplot2 library was used for exploratory 
data analysis and plotting results. 
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The work described in my thesis was aimed at identifying new genes and 
pathway involved in women fertility and indeed we succeeded in the task. 
GWAS design in general, over the last decade, has led to a remarkably 
diverse set of discoveries in human genetics especially thanks to a 
continuously increase of samples number and to the possibility to study 
common and rare variants. For all complex traits, which have been studied 
with this kind of approach, it was shown that many genetic loci could 
contribute to the genetic variation of the trait in population. On average the 
proportion of genetic variance explained by each variant is very small and the 
genetic architecture of most traits studied is dominated by the additive effect 
of hundreds of variants with small effect. My results reveal a similar trend for 
fertility: for age at menarche, the 389 independent signals explained 7.4% of 
the population variance, for age at menopause the top 54 SNPs explain 6% of 
the variance that increase to 21% if we consider the top 29,958 independent 
SNPs with association p-value<0.05. 
Loci identification may lead to new clues to the understanding of the 
mechanisms controlling each trait. Also in our case large efforts have been 
made in order to understand some of the biological mechanisms. 
Regarding age at menarche the results of three GWAS showed that the effect 
of the variants and their heritability were higher for early versus late puberty 
timing. We discovered a significant role of imprinted genes in the regulation of 
age at menarche, namely we found that rare coding mutations in MKRN3 and 
DLK1 genes, when paternally inherited and expressed, confer a substantial 
decrease of age at menarche. 
The relationship between puberty timing and BMI was already known 
(Mohamad et al., 2013) but our observations confirmed a strong inverse 
genetic correlation between age at menarche and BMI: earlier age of 
menarche is associated with higher BMI. 
In addition the results show a complex association among age at menarche, 
BMI and adult cancer risk: it was reported (Hamajima et al., 2012) that lower 
adolescent BMI and earlier menarche were associated with a higher breast 
cancer risk. Adjusted for BMI, in order to see the effect of menarche, results of 
our analysis show evidence for association of an increased age at menarche 
with a lower risk of breast cancer estrogen receptor positive and ovarian 
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cancer. We speculate that this could be mediated by a shorter duration of 
exposure to sex steroids. 
Also age of menopause is associated with cancer risk for the same reason, 
the prolonged exposure of estrogen and progesterone. Individuals carrying a 
higher number of variants that show an increase of age at menopause are 
more susceptible to breast cancer. 
Some of the loci for menopause confirmed the involvement of hypothalamic 
or pituitary activity in controlling age of menopause: 5 loci, significantly 
associated with AAM, contain genes reported to be responsible for 
hypogonadotropic hypogonadism. This is a condition characterized by a low 
level of circulating estrogen and progesterone in females, caused by an 
impaired secretion of follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH) by the pituitary gland in the brain. 
Interestingly, two-thirds of the significant loci associated with age at 
menopause have a substantial role in DNA damage response, a remarkable 
excess of DDR genes in comparison to the number originally estimated. 
BRCA1 is one of the genes in the list. It encodes a protein involved in 
repairing damaged DNA. Rare loss of function mutations in this gene were 
associated with breast cancer predisposition but variants in this gene had not 
been mapped to any complex trait. Our data showed that BRCA1 directly 
inhibits the transcriptional activation of ERα and thus variants that reduce 
BRCA1 expression altered estrogen signaling. 
We identified 13 genes involved in homologous recombination-mediator 
repair. Two of the genes are specific for meiotic repair (MSH5 and DMC1): 
aberrant meiotic recombination can cause meiotic arrest and affect the 
viability of oocytes. We know that menopause occurs when the number of 
oocytes falls below approximately 1,000 (Gold, 2011) and thus a process that 
affects the size of the oocytes pool may affect age at menopause. 
Also other repair mechanisms, mismatch repair, base-excision repair, mitotic 
repair and repair checkpoints are involved and due to the characteristics of 
oocyte, the prolonged state of cell cycle arrest until 50-60 years, oocyte may 
be particularly sensitive to DNA damage and the aberrant repair through life 
could affect the rate of oocyte loss as during female life the majority of oocyte 
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are lost by atresia 
Only 2 genes, MSH6 and SPPL3, are significantly associated with both 
menarche and menopause. The first gene, MSH6, is one of the genes 
involved in DDR pathway whereas the second common gene, a Signal 
Peptide Peptidase, has no known function. All together, the results suggest 
that the two traits are regulated quite differently. 
Even though traits as age at first birth and number of children ever born are 
subject to individual choice, to cultural, social and economic environment, we 
demonstrated the importance of steroidogenesis pathway, in fact a significant 
signal in both AFB and NEB analysis is on CRTC2 gene. The protein encoded 
by this gene has an important mediator role in follicole-stimulating hormone 
(FSH) and transforming growth factor (TGF)-beta1 stimulated steroidogenesis 
in ovarian granulosa cell, the biological process by which steroids are 
generated from cholesterol. 
A common scenario in these results is also the evidence of involvement of 
genes with a role in cell cycle progression due to a control in methylation and 
expression of other genes. 
Two genes, FOXP2 and FBXL17, are significant associated respectively in 
AFB and NEB analysis and are in common with significant signal in 
menarche. The FOXP2 encode for a transcription factor that may regulate 
hundreds of genes, it is active in several tissues, including the brain, both 
before and after birth. On gene FBXL17 very few details are known, it forms a 
complex with SKP1 and cullin protein that acts as protein-ubiquitin ligases. 
AMH GWAS on INGI women showed suggestive signal on gene POLDIP3, 
involved in regulation of translation, overexpressed in the ovary and “DNA 
replication” pathway enrichment. 
We demonstrate the improvement of imputation quality with Italian reference 
panel in comparison with 1000G phase I panel, especially for rare variants. 
Analysis on AMH in endometriosis patients allowed to emphasize the 
importance of ovarian cortical tissue cryopreservation for women that will 
have surgery for endometriosis. In fact, our results indicate that ovarian 
reserve in women with endometriosis and with more than 36 years decrease 
more rapidly than in healthy women. 
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In conclusion, many new genes and biological pathways were discovered that 
shed light on a number of reproduction related traits: they may be relevant for 
predicting early infertility before entry into menopause. The identification of 
novel genes and pathways will certainly provide new targets for biomarkers 
discovery and to study new drugs for personalized medicine. 
 
Our approach emphasizes the ways in which disease risks are unique and 
different in patients with same disease but with different genome variants. 
Those disease risks are based on the predispositions written in genome at 
birth, combined with lifestyle and environment. 
Nowadays the possibility to look and to integrate “omics” data of different 
types to advance hypotheses and answer to biological questions is increased. 
Genomics data, analyzed together with trascriptomics, epigenomics, 
proteomics and metabolomics could be an enormous and extraordinary 
source that, analyzed with appropriate bioinformatics softwares, could bring a 
great advantage in personalized medicine. 
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